Gene Symbol | Gene ID | Gene Info |
---|---|---|
RCOR1
|
ENSG00000089902.8 | REST corepressor 1 |
MTA3
|
ENSG00000057935.9 | metastasis associated 1 family member 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_42795897_42796286 | MTA3 | 205 | 0.956825 | 0.95 | 9.8e-05 | Click! |
chr2_42721214_42722254 | MTA3 | 25 | 0.904333 | 0.91 | 7.7e-04 | Click! |
chr2_42795246_42795414 | MTA3 | 145 | 0.970331 | 0.85 | 3.5e-03 | Click! |
chr2_42739632_42739783 | MTA3 | 17998 | 0.194023 | 0.67 | 5.0e-02 | Click! |
chr2_42796417_42796822 | MTA3 | 95 | 0.978273 | 0.56 | 1.2e-01 | Click! |
chr14_103058426_103058640 | RCOR1 | 465 | 0.803052 | 0.91 | 5.7e-04 | Click! |
chr14_103059384_103059698 | RCOR1 | 308 | 0.890535 | 0.86 | 3.1e-03 | Click! |
chr14_103058041_103058305 | RCOR1 | 825 | 0.602658 | 0.81 | 7.5e-03 | Click! |
chr14_103059006_103059157 | RCOR1 | 83 | 0.969485 | 0.75 | 1.9e-02 | Click! |
chr14_103057530_103057890 | RCOR1 | 1288 | 0.428985 | 0.69 | 3.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_30241996_30242439 | 7.01 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
39 |
0.68 |
chr1_224621785_224622065 | 6.51 |
WDR26 |
WD repeat domain 26 |
76 |
0.98 |
chr20_62185445_62185854 | 5.54 |
C20orf195 |
chromosome 20 open reading frame 195 |
153 |
0.91 |
chr9_33446798_33447442 | 5.09 |
AQP3 |
aquaporin 3 (Gill blood group) |
489 |
0.76 |
chr15_52970940_52971318 | 4.84 |
FAM214A |
family with sequence similarity 214, member A |
176 |
0.96 |
chr12_19592806_19593080 | 4.73 |
AEBP2 |
AE binding protein 2 |
310 |
0.92 |
chr19_4064959_4065214 | 4.63 |
ZBTB7A |
zinc finger and BTB domain containing 7A |
644 |
0.56 |
chr17_54670102_54670610 | 4.62 |
NOG |
noggin |
704 |
0.8 |
chr4_25864719_25864897 | 4.56 |
SEL1L3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
227 |
0.95 |
chr1_78148853_78149141 | 4.52 |
ZZZ3 |
zinc finger, ZZ-type containing 3 |
62 |
0.97 |
chr9_100745668_100746275 | 4.49 |
ANP32B |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
328 |
0.85 |
chr17_37353212_37353473 | 4.45 |
CACNB1 |
calcium channel, voltage-dependent, beta 1 subunit |
613 |
0.61 |
chr6_3457126_3457485 | 4.37 |
SLC22A23 |
solute carrier family 22, member 23 |
49 |
0.99 |
chr9_140008700_140009150 | 4.37 |
DPP7 |
dipeptidyl-peptidase 7 |
231 |
0.78 |
chr16_85588474_85589100 | 4.36 |
GSE1 |
Gse1 coiled-coil protein |
56228 |
0.12 |
chr10_22610168_22610350 | 4.33 |
BMI1 |
BMI1 polycomb ring finger oncogene |
119 |
0.95 |
chr3_184080089_184080493 | 4.30 |
POLR2H |
polymerase (RNA) II (DNA directed) polypeptide H |
112 |
0.89 |
chr2_129076576_129077236 | 4.25 |
HS6ST1 |
heparan sulfate 6-O-sulfotransferase 1 |
755 |
0.73 |
chr8_41511279_41511901 | 4.20 |
NKX6-3 |
NK6 homeobox 3 |
2735 |
0.18 |
chr2_214014184_214015200 | 4.12 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
273 |
0.95 |
chr14_99712277_99712758 | 4.12 |
AL109767.1 |
|
16768 |
0.21 |
chr4_184426878_184427177 | 4.10 |
ING2 |
inhibitor of growth family, member 2 |
208 |
0.91 |
chr3_152553238_152553744 | 4.09 |
P2RY1 |
purinergic receptor P2Y, G-protein coupled, 1 |
755 |
0.8 |
chr10_124134278_124134675 | 4.09 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
126 |
0.96 |
chr19_44283632_44284486 | 4.07 |
KCNN4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1350 |
0.33 |
chr9_137533577_137533991 | 4.05 |
COL5A1 |
collagen, type V, alpha 1 |
164 |
0.96 |
chr6_143266416_143266570 | 4.04 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
155 |
0.97 |
chr1_6674280_6674659 | 4.03 |
KLHL21 |
kelch-like family member 21 |
151 |
0.86 |
chr18_77153881_77154299 | 4.00 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
1766 |
0.42 |
chr18_14431127_14431407 | 3.94 |
ENSG00000200132 |
. |
100514 |
0.07 |
chr7_6543400_6543638 | 3.92 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
19646 |
0.12 |
chr4_160024606_160025057 | 3.92 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
499 |
0.78 |
chr19_42758223_42758597 | 3.92 |
ERF |
Ets2 repressor factor |
359 |
0.64 |
chr14_61190612_61190839 | 3.91 |
SIX4 |
SIX homeobox 4 |
127 |
0.97 |
chr6_36164778_36164969 | 3.89 |
RP1-179N16.6 |
|
107 |
0.53 |
chr19_31840219_31840556 | 3.88 |
TSHZ3 |
teashirt zinc finger homeobox 3 |
66 |
0.92 |
chr8_38034540_38035180 | 3.88 |
LSM1 |
LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
626 |
0.41 |
chr8_21777326_21777532 | 3.87 |
XPO7 |
exportin 7 |
161 |
0.95 |
chr10_43249759_43250194 | 3.87 |
BMS1 |
BMS1 ribosome biogenesis factor |
28273 |
0.19 |
chrX_153095524_153095861 | 3.87 |
PDZD4 |
PDZ domain containing 4 |
121 |
0.93 |
chrX_149108264_149108672 | 3.84 |
LINC00894 |
long intergenic non-protein coding RNA 894 |
94 |
0.95 |
chr21_45660934_45661560 | 3.83 |
ICOSLG |
inducible T-cell co-stimulator ligand |
398 |
0.76 |
chr11_57243949_57244502 | 3.82 |
RP11-624G17.3 |
|
782 |
0.45 |
chr12_124018329_124018683 | 3.81 |
RILPL1 |
Rab interacting lysosomal protein-like 1 |
241 |
0.89 |
chr1_44399484_44399885 | 3.78 |
ARTN |
artemin |
166 |
0.92 |
chr2_159313710_159313861 | 3.73 |
PKP4 |
plakophilin 4 |
161 |
0.83 |
chr17_7308279_7308430 | 3.72 |
NLGN2 |
neuroligin 2 |
161 |
0.77 |
chr19_9902856_9903204 | 3.71 |
ZNF846 |
zinc finger protein 846 |
743 |
0.48 |
chr1_86172923_86174087 | 3.69 |
ZNHIT6 |
zinc finger, HIT-type containing 6 |
596 |
0.83 |
chr22_36424159_36424401 | 3.69 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
193 |
0.97 |
chr6_112193826_112194267 | 3.66 |
FYN |
FYN oncogene related to SRC, FGR, YES |
194 |
0.97 |
chr11_71934379_71934736 | 3.66 |
INPPL1 |
inositol polyphosphate phosphatase-like 1 |
188 |
0.89 |
chr19_17905710_17906188 | 3.64 |
B3GNT3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
4 |
0.96 |
chr17_73874128_73874630 | 3.63 |
TRIM47 |
tripartite motif containing 47 |
102 |
0.91 |
chr8_104383694_104384008 | 3.63 |
CTHRC1 |
collagen triple helix repeat containing 1 |
73 |
0.97 |
chr11_67140664_67140882 | 3.62 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
435 |
0.64 |
chr1_201708984_201709277 | 3.61 |
NAV1 |
neuron navigator 1 |
134 |
0.93 |
chr21_42539308_42539931 | 3.60 |
BACE2 |
beta-site APP-cleaving enzyme 2 |
109 |
0.53 |
chr2_208394784_208394971 | 3.60 |
CREB1 |
cAMP responsive element binding protein 1 |
49 |
0.84 |
chr1_229406887_229407131 | 3.60 |
RAB4A |
RAB4A, member RAS oncogene family |
130 |
0.95 |
chr21_45661777_45662023 | 3.59 |
ICOSLG |
inducible T-cell co-stimulator ligand |
1051 |
0.37 |
chr17_7788638_7788948 | 3.59 |
LSMD1 |
LSM domain containing 1 |
266 |
0.71 |
chr2_219082127_219082488 | 3.58 |
ARPC2 |
actin related protein 2/3 complex, subunit 2, 34kDa |
374 |
0.79 |
chrX_40014424_40014731 | 3.58 |
BCOR |
BCL6 corepressor |
8695 |
0.31 |
chr5_154062019_154062378 | 3.56 |
ENSG00000221552 |
. |
3138 |
0.22 |
chr4_2010073_2010242 | 3.56 |
NELFA |
negative elongation factor complex member A |
405 |
0.8 |
chr6_158958027_158958458 | 3.56 |
TMEM181 |
transmembrane protein 181 |
774 |
0.72 |
chr9_6008187_6008379 | 3.55 |
KIAA2026 |
KIAA2026 |
382 |
0.53 |
chr14_100070851_100071273 | 3.55 |
CCDC85C |
coiled-coil domain containing 85C |
699 |
0.67 |
chrX_25020829_25021251 | 3.54 |
ARX |
aristaless related homeobox |
13025 |
0.26 |
chr16_30934888_30935156 | 3.54 |
FBXL19 |
F-box and leucine-rich repeat protein 19 |
396 |
0.43 |
chr18_46066026_46066570 | 3.53 |
CTIF |
CBP80/20-dependent translation initiation factor |
61 |
0.98 |
chr6_130341357_130341579 | 3.53 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
168 |
0.97 |
chr22_37956672_37957106 | 3.53 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
402 |
0.77 |
chr9_136150814_136151142 | 3.52 |
ENSG00000201843 |
. |
26975 |
0.09 |
chr19_36391130_36391439 | 3.52 |
NFKBID |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta |
268 |
0.8 |
chr6_143267112_143267462 | 3.52 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
949 |
0.67 |
chr12_108523289_108523785 | 3.52 |
WSCD2 |
WSC domain containing 2 |
26 |
0.99 |
chr8_124553811_124554260 | 3.51 |
FBXO32 |
F-box protein 32 |
589 |
0.77 |
chr21_27011889_27012538 | 3.51 |
JAM2 |
junctional adhesion molecule 2 |
303 |
0.91 |
chr3_150126449_150126853 | 3.50 |
TSC22D2 |
TSC22 domain family, member 2 |
529 |
0.86 |
chr3_194354154_194354713 | 3.50 |
TMEM44 |
transmembrane protein 44 |
15 |
0.93 |
chr19_17008131_17008363 | 3.49 |
CPAMD8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
1221 |
0.33 |
chr5_180076100_180076485 | 3.48 |
FLT4 |
fms-related tyrosine kinase 4 |
308 |
0.9 |
chr12_49182930_49183135 | 3.48 |
ADCY6 |
adenylate cyclase 6 |
212 |
0.88 |
chr14_105218972_105219273 | 3.47 |
SIVA1 |
SIVA1, apoptosis-inducing factor |
315 |
0.83 |
chr3_28617160_28617794 | 3.46 |
LINC00693 |
long intergenic non-protein coding RNA 693 |
425 |
0.9 |
chr1_27023955_27024278 | 3.46 |
ARID1A |
AT rich interactive domain 1A (SWI-like) |
1221 |
0.38 |
chr5_102594552_102594973 | 3.45 |
C5orf30 |
chromosome 5 open reading frame 30 |
25 |
0.98 |
chr8_80680121_80680375 | 3.44 |
HEY1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
150 |
0.97 |
chr6_150389447_150390345 | 3.44 |
ULBP3 |
UL16 binding protein 3 |
306 |
0.9 |
chr1_226250525_226250815 | 3.44 |
H3F3A |
H3 histone, family 3A |
255 |
0.86 |
chr7_3083277_3083584 | 3.44 |
CARD11 |
caspase recruitment domain family, member 11 |
49 |
0.98 |
chr14_71275780_71276171 | 3.42 |
MAP3K9 |
mitogen-activated protein kinase kinase kinase 9 |
87 |
0.98 |
chr17_38083072_38083824 | 3.42 |
ORMDL3 |
ORM1-like 3 (S. cerevisiae) |
34 |
0.96 |
chr3_13920477_13920889 | 3.41 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
935 |
0.64 |
chr10_103874843_103875295 | 3.41 |
LDB1 |
LIM domain binding 1 |
366 |
0.82 |
chr13_110439180_110439367 | 3.40 |
IRS2 |
insulin receptor substrate 2 |
358 |
0.92 |
chr13_50698385_50698672 | 3.39 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
42221 |
0.15 |
chr22_25961017_25961859 | 3.39 |
ADRBK2 |
adrenergic, beta, receptor kinase 2 |
622 |
0.55 |
chr2_159313885_159314371 | 3.39 |
PKP4 |
plakophilin 4 |
504 |
0.62 |
chr1_145575307_145575914 | 3.39 |
PIAS3 |
protein inhibitor of activated STAT, 3 |
286 |
0.83 |
chr1_201709300_201709781 | 3.38 |
NAV1 |
neuron navigator 1 |
544 |
0.66 |
chr17_15554007_15555167 | 3.38 |
RP11-640I15.1 |
|
317 |
0.52 |
chr20_50158140_50158637 | 3.38 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
870 |
0.72 |
chr1_154298186_154298848 | 3.37 |
ATP8B2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
488 |
0.64 |
chr7_559951_560161 | 3.36 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
123 |
0.97 |
chr10_80733781_80734431 | 3.36 |
ZMIZ1-AS1 |
ZMIZ1 antisense RNA 1 |
11955 |
0.29 |
chr3_43663127_43663412 | 3.34 |
ANO10 |
anoctamin 10 |
120 |
0.98 |
chr15_72766829_72767031 | 3.34 |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
56 |
0.98 |
chr9_139438785_139439162 | 3.33 |
NOTCH1 |
notch 1 |
1341 |
0.19 |
chr3_150126096_150126425 | 3.33 |
TSC22D2 |
TSC22 domain family, member 2 |
138 |
0.98 |
chr5_74348480_74348736 | 3.33 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
21884 |
0.25 |
chr3_25705652_25705988 | 3.33 |
TOP2B |
topoisomerase (DNA) II beta 180kDa |
32 |
0.93 |
chr16_11680919_11681311 | 3.33 |
LITAF |
lipopolysaccharide-induced TNF factor |
12 |
0.98 |
chr20_56284812_56285148 | 3.32 |
PMEPA1 |
prostate transmembrane protein, androgen induced 1 |
22 |
0.99 |
chr3_185541992_185542409 | 3.32 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
600 |
0.79 |
chr1_101701336_101702269 | 3.32 |
RP4-575N6.4 |
|
282 |
0.74 |
chr22_26823969_26824219 | 3.31 |
ASPHD2 |
aspartate beta-hydroxylase domain containing 2 |
1145 |
0.46 |
chr2_241374262_241374834 | 3.31 |
GPC1 |
glypican 1 |
540 |
0.75 |
chr7_79764314_79764804 | 3.31 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
46 |
0.99 |
chr21_16437486_16437824 | 3.31 |
NRIP1 |
nuclear receptor interacting protein 1 |
334 |
0.93 |
chr20_57582352_57582503 | 3.31 |
CTSZ |
cathepsin Z |
125 |
0.95 |
chr15_69110570_69110988 | 3.30 |
ANP32A |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
2446 |
0.33 |
chr8_145582294_145582976 | 3.30 |
SLC52A2 |
solute carrier family 52 (riboflavin transporter), member 2 |
15 |
0.86 |
chr8_1771644_1772131 | 3.30 |
ARHGEF10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
255 |
0.93 |
chr19_48112848_48113246 | 3.30 |
GLTSCR1 |
glioma tumor suppressor candidate region gene 1 |
667 |
0.63 |
chr4_6201674_6201940 | 3.30 |
JAKMIP1 |
janus kinase and microtubule interacting protein 1 |
475 |
0.88 |
chr7_116502642_116502981 | 3.29 |
CAPZA2 |
capping protein (actin filament) muscle Z-line, alpha 2 |
157 |
0.96 |
chr17_59940229_59940941 | 3.29 |
BRIP1 |
BRCA1 interacting protein C-terminal helicase 1 |
120 |
0.97 |
chr3_183947999_183948171 | 3.29 |
VWA5B2 |
von Willebrand factor A domain containing 5B2 |
132 |
0.92 |
chr17_35969081_35969470 | 3.28 |
SYNRG |
synergin, gamma |
154 |
0.82 |
chr11_69457709_69458273 | 3.28 |
CCND1 |
cyclin D1 |
2017 |
0.36 |
chr15_41199252_41199466 | 3.28 |
VPS18 |
vacuolar protein sorting 18 homolog (S. cerevisiae) |
12694 |
0.11 |
chr9_33447649_33448227 | 3.27 |
AQP3 |
aquaporin 3 (Gill blood group) |
329 |
0.86 |
chr22_39638595_39638905 | 3.27 |
PDGFB |
platelet-derived growth factor beta polypeptide |
271 |
0.89 |
chr19_42758603_42759183 | 3.26 |
ERF |
Ets2 repressor factor |
106 |
0.78 |
chr10_3109810_3110416 | 3.26 |
PFKP |
phosphofructokinase, platelet |
401 |
0.91 |
chr18_21594079_21594473 | 3.25 |
TTC39C |
tetratricopeptide repeat domain 39C |
108 |
0.94 |
chr1_155948069_155948671 | 3.25 |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
52 |
0.71 |
chr20_48806660_48807137 | 3.25 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
478 |
0.82 |
chr5_61602291_61602746 | 3.25 |
KIF2A |
kinesin heavy chain member 2A |
237 |
0.95 |
chr3_110790117_110790473 | 3.25 |
PVRL3-AS1 |
PVRL3 antisense RNA 1 |
76 |
0.78 |
chr17_27894284_27894699 | 3.23 |
TP53I13 |
tumor protein p53 inducible protein 13 |
293 |
0.48 |
chr8_61429545_61429985 | 3.23 |
RAB2A |
RAB2A, member RAS oncogene family |
25 |
0.98 |
chr1_147072028_147072317 | 3.23 |
ACP6 |
acid phosphatase 6, lysophosphatidic |
58944 |
0.12 |
chr16_87799045_87799225 | 3.22 |
KLHDC4 |
kelch domain containing 4 |
370 |
0.86 |
chr15_34658899_34659312 | 3.21 |
LPCAT4 |
lysophosphatidylcholine acyltransferase 4 |
374 |
0.77 |
chr11_64013126_64013464 | 3.21 |
PPP1R14B |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
7 |
0.62 |
chr12_94542285_94542597 | 3.21 |
PLXNC1 |
plexin C1 |
58 |
0.98 |
chr11_57281986_57282423 | 3.21 |
SLC43A1 |
solute carrier family 43 (amino acid system L transporter), member 1 |
116 |
0.93 |
chr2_233562030_233562535 | 3.21 |
GIGYF2 |
GRB10 interacting GYF protein 2 |
220 |
0.91 |
chrX_102631036_102631748 | 3.21 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
57 |
0.97 |
chr19_51228076_51228227 | 3.19 |
CLEC11A |
C-type lectin domain family 11, member A |
1371 |
0.27 |
chr2_676152_676450 | 3.19 |
TMEM18 |
transmembrane protein 18 |
403 |
0.72 |
chr17_17685460_17685915 | 3.19 |
RAI1 |
retinoic acid induced 1 |
241 |
0.87 |
chr2_204399368_204399945 | 3.18 |
RAPH1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
329 |
0.93 |
chr6_36098764_36099262 | 3.18 |
MAPK13 |
mitogen-activated protein kinase 13 |
573 |
0.74 |
chr19_53237403_53237997 | 3.17 |
ZNF611 |
zinc finger protein 611 |
597 |
0.71 |
chr1_6053105_6053704 | 3.17 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
633 |
0.53 |
chr12_67463178_67463498 | 3.17 |
CAND1 |
cullin-associated and neddylation-dissociated 1 |
199723 |
0.03 |
chr2_158732679_158732987 | 3.17 |
UPP2 |
uridine phosphorylase 2 |
381 |
0.53 |
chr9_130616400_130616906 | 3.17 |
ENG |
endoglin |
262 |
0.8 |
chr3_47051058_47051537 | 3.17 |
NBEAL2 |
neurobeachin-like 2 |
4526 |
0.22 |
chr19_14359519_14359890 | 3.16 |
ENSG00000240803 |
. |
35840 |
0.12 |
chr7_141401297_141401770 | 3.16 |
KIAA1147 |
KIAA1147 |
118 |
0.94 |
chr6_20402144_20402837 | 3.15 |
E2F3 |
E2F transcription factor 3 |
92 |
0.96 |
chr6_36164322_36164500 | 3.14 |
BRPF3 |
bromodomain and PHD finger containing, 3 |
110 |
0.88 |
chr17_2240971_2241301 | 3.14 |
SGSM2 |
small G protein signaling modulator 2 |
220 |
0.6 |
chr16_14165273_14165729 | 3.14 |
MKL2 |
MKL/myocardin-like 2 |
305 |
0.94 |
chr18_42259133_42259527 | 3.14 |
SETBP1 |
SET binding protein 1 |
808 |
0.79 |
chr19_2236099_2236294 | 3.14 |
PLEKHJ1 |
pleckstrin homology domain containing, family J member 1 |
75 |
0.77 |
chr1_154981282_154981433 | 3.13 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5567 |
0.08 |
chr2_161349313_161349923 | 3.13 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
411 |
0.9 |
chr12_58239685_58240153 | 3.12 |
CTDSP2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
568 |
0.59 |
chr12_42877069_42877413 | 3.12 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
175 |
0.94 |
chr21_38378685_38379077 | 3.12 |
RIPPLY3 |
ripply transcriptional repressor 3 |
18 |
0.97 |
chr17_36715319_36715684 | 3.12 |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
4159 |
0.19 |
chr6_83903145_83903588 | 3.11 |
RWDD2A |
RWD domain containing 2A |
262 |
0.49 |
chr1_153918448_153918692 | 3.11 |
DENND4B |
DENN/MADD domain containing 4B |
602 |
0.54 |
chr17_36714613_36715266 | 3.11 |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
4721 |
0.18 |
chr2_174829537_174830027 | 3.11 |
SP3 |
Sp3 transcription factor |
501 |
0.89 |
chr20_4129435_4129658 | 3.11 |
SMOX |
spermine oxidase |
36 |
0.98 |
chr3_42544302_42544877 | 3.11 |
VIPR1 |
vasoactive intestinal peptide receptor 1 |
474 |
0.79 |
chr1_36622732_36623311 | 3.11 |
MAP7D1 |
MAP7 domain containing 1 |
205 |
0.92 |
chr9_129485287_129485658 | 3.10 |
ENSG00000266403 |
. |
4860 |
0.26 |
chr17_66201588_66201894 | 3.10 |
AMZ2 |
archaelysin family metallopeptidase 2 |
41974 |
0.12 |
chr17_43299403_43299689 | 3.10 |
CTD-2020K17.1 |
|
43 |
0.75 |
chr8_103424629_103424951 | 3.09 |
UBR5 |
ubiquitin protein ligase E3 component n-recognin 5 |
127 |
0.96 |
chr6_35420024_35420358 | 3.09 |
FANCE |
Fanconi anemia, complementation group E |
53 |
0.97 |
chr4_37892491_37892870 | 3.09 |
TBC1D1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
28 |
0.98 |
chr6_37138253_37138656 | 3.09 |
PIM1 |
pim-1 oncogene |
475 |
0.81 |
chrX_68723756_68724064 | 3.09 |
ENSG00000264604 |
. |
638 |
0.63 |
chr16_3508046_3508197 | 3.09 |
NAA60 |
N(alpha)-acetyltransferase 60, NatF catalytic subunit |
9 |
0.96 |
chr15_34728874_34729538 | 3.08 |
GOLGA8A |
golgin A8 family, member A |
29318 |
0.13 |
chr7_145813457_145813835 | 3.08 |
CNTNAP2 |
contactin associated protein-like 2 |
193 |
0.96 |
chr11_133788574_133788755 | 3.08 |
ENSG00000264919 |
. |
20188 |
0.18 |
chr17_1928692_1929031 | 3.08 |
RTN4RL1 |
reticulon 4 receptor-like 1 |
222 |
0.83 |
chr2_65662974_65663283 | 3.07 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
3357 |
0.31 |
chr7_2563263_2563619 | 3.07 |
ENSG00000264357 |
. |
3267 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 31.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
6.1 | 18.2 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
5.6 | 16.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
4.8 | 4.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
4.8 | 4.8 | GO:0010761 | fibroblast migration(GO:0010761) |
4.4 | 13.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
4.3 | 12.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
4.2 | 12.7 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
4.0 | 12.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
4.0 | 15.9 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
3.9 | 3.9 | GO:0051014 | actin filament severing(GO:0051014) |
3.7 | 11.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
3.7 | 3.7 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
3.6 | 3.6 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
3.5 | 3.5 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
3.5 | 10.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.5 | 3.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
3.5 | 3.5 | GO:0007412 | axon target recognition(GO:0007412) |
3.5 | 13.9 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
3.5 | 17.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
3.4 | 10.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
3.4 | 10.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
3.4 | 10.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
3.3 | 10.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.3 | 9.9 | GO:0034063 | stress granule assembly(GO:0034063) |
3.3 | 3.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
3.2 | 3.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
3.2 | 9.6 | GO:0000089 | mitotic metaphase(GO:0000089) |
3.2 | 3.2 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
3.2 | 6.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
3.2 | 3.2 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
3.1 | 12.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
3.1 | 12.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
3.1 | 3.1 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
3.1 | 15.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
2.9 | 5.8 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
2.9 | 11.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
2.9 | 8.6 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
2.9 | 8.6 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
2.9 | 5.7 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
2.9 | 2.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
2.8 | 2.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
2.8 | 8.5 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
2.8 | 8.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
2.8 | 2.8 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
2.8 | 5.6 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
2.8 | 8.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
2.8 | 8.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
2.8 | 5.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
2.8 | 8.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
2.8 | 2.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.8 | 8.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
2.8 | 8.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.8 | 13.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
2.7 | 16.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
2.7 | 8.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
2.7 | 8.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.7 | 10.7 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
2.7 | 13.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.7 | 2.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
2.6 | 7.9 | GO:0045576 | mast cell activation(GO:0045576) |
2.6 | 13.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
2.6 | 5.3 | GO:0007144 | female meiosis I(GO:0007144) |
2.6 | 2.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
2.6 | 5.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.6 | 20.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.6 | 7.7 | GO:0070295 | renal water absorption(GO:0070295) |
2.6 | 7.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.6 | 5.1 | GO:0022009 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
2.6 | 10.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
2.5 | 2.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
2.5 | 12.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
2.5 | 15.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
2.5 | 2.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.5 | 20.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
2.5 | 10.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
2.5 | 27.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
2.4 | 31.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
2.4 | 12.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
2.4 | 9.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.4 | 4.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.4 | 2.4 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
2.4 | 2.4 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
2.4 | 2.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
2.4 | 7.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
2.4 | 7.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
2.4 | 23.9 | GO:0002467 | germinal center formation(GO:0002467) |
2.4 | 7.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
2.4 | 7.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
2.4 | 9.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.4 | 11.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
2.4 | 7.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.4 | 7.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
2.3 | 9.4 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
2.3 | 4.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.3 | 4.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
2.3 | 6.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
2.3 | 4.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
2.3 | 6.9 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
2.3 | 9.2 | GO:0015853 | adenine transport(GO:0015853) |
2.3 | 11.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
2.3 | 9.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
2.3 | 2.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
2.3 | 36.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
2.3 | 6.8 | GO:2000757 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
2.3 | 6.8 | GO:0001821 | histamine secretion(GO:0001821) |
2.2 | 6.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
2.2 | 2.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
2.2 | 6.7 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
2.2 | 42.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
2.2 | 2.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
2.2 | 8.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
2.2 | 2.2 | GO:0061054 | dermatome development(GO:0061054) |
2.2 | 11.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
2.2 | 11.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
2.2 | 2.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
2.2 | 6.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
2.2 | 6.6 | GO:0016559 | peroxisome fission(GO:0016559) |
2.2 | 2.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
2.2 | 4.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.2 | 10.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
2.2 | 2.2 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
2.2 | 6.5 | GO:0030091 | protein repair(GO:0030091) |
2.1 | 4.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
2.1 | 10.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.1 | 6.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.1 | 12.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
2.1 | 2.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
2.1 | 10.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
2.1 | 8.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
2.1 | 6.3 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
2.1 | 2.1 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
2.1 | 25.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
2.1 | 6.2 | GO:0001743 | optic placode formation(GO:0001743) |
2.1 | 16.5 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
2.1 | 2.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
2.1 | 12.3 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
2.0 | 4.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
2.0 | 6.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.0 | 2.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
2.0 | 2.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
2.0 | 6.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
2.0 | 6.1 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
2.0 | 10.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
2.0 | 14.1 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
2.0 | 18.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
2.0 | 10.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.0 | 23.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
2.0 | 8.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
2.0 | 8.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
2.0 | 3.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
2.0 | 5.9 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
2.0 | 5.9 | GO:0005997 | xylulose metabolic process(GO:0005997) |
2.0 | 5.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.0 | 13.7 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
2.0 | 9.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.0 | 7.8 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.9 | 3.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.9 | 11.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.9 | 7.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
1.9 | 3.9 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.9 | 1.9 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
1.9 | 3.8 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
1.9 | 11.5 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
1.9 | 7.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.9 | 19.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
1.9 | 11.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.9 | 1.9 | GO:0050790 | regulation of catalytic activity(GO:0050790) |
1.9 | 1.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.9 | 5.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.9 | 7.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
1.9 | 9.4 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
1.9 | 5.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.9 | 16.9 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
1.9 | 1.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.9 | 13.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.9 | 13.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
1.9 | 9.4 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
1.9 | 20.6 | GO:0050798 | activated T cell proliferation(GO:0050798) |
1.9 | 24.3 | GO:0017145 | stem cell division(GO:0017145) |
1.9 | 18.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
1.9 | 1.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
1.9 | 5.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.9 | 24.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.9 | 11.2 | GO:0006983 | ER overload response(GO:0006983) |
1.9 | 5.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.9 | 16.7 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
1.9 | 7.4 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
1.9 | 1.9 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
1.9 | 7.4 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.8 | 14.7 | GO:0051322 | anaphase(GO:0051322) |
1.8 | 11.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.8 | 1.8 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
1.8 | 3.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.8 | 1.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.8 | 1.8 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
1.8 | 5.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.8 | 5.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.8 | 3.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.8 | 1.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
1.8 | 5.4 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.8 | 1.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.8 | 19.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.8 | 9.0 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
1.8 | 3.6 | GO:0051340 | regulation of ligase activity(GO:0051340) |
1.8 | 1.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.8 | 1.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.8 | 1.8 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.8 | 1.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.8 | 3.6 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
1.8 | 5.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
1.8 | 5.3 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
1.8 | 5.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.8 | 1.8 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
1.8 | 17.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
1.8 | 5.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
1.8 | 8.9 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
1.8 | 5.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.8 | 1.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.8 | 5.3 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
1.8 | 3.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.8 | 1.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.8 | 12.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.8 | 1.8 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
1.8 | 12.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.7 | 3.5 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
1.7 | 1.7 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
1.7 | 1.7 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
1.7 | 1.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.7 | 1.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.7 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.7 | 6.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.7 | 5.2 | GO:0001675 | acrosome assembly(GO:0001675) |
1.7 | 3.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.7 | 18.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
1.7 | 1.7 | GO:0060674 | placenta blood vessel development(GO:0060674) |
1.7 | 5.1 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
1.7 | 1.7 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
1.7 | 5.1 | GO:0051642 | centrosome localization(GO:0051642) |
1.7 | 5.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.7 | 11.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.7 | 5.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
1.7 | 15.3 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
1.7 | 8.5 | GO:0033483 | gas homeostasis(GO:0033483) |
1.7 | 3.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
1.7 | 11.9 | GO:0032456 | endocytic recycling(GO:0032456) |
1.7 | 3.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.7 | 11.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.7 | 10.1 | GO:0045116 | protein neddylation(GO:0045116) |
1.7 | 3.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.7 | 8.4 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.7 | 3.4 | GO:0051665 | membrane raft localization(GO:0051665) |
1.7 | 1.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.7 | 5.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.7 | 11.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.7 | 6.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
1.7 | 6.7 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.7 | 3.3 | GO:1903332 | regulation of protein folding(GO:1903332) |
1.7 | 8.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.7 | 3.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
1.7 | 6.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.6 | 1.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
1.6 | 8.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.6 | 6.6 | GO:0032202 | telomere assembly(GO:0032202) |
1.6 | 3.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.6 | 6.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.6 | 16.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
1.6 | 4.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.6 | 3.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.6 | 6.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.6 | 3.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
1.6 | 11.4 | GO:0031529 | ruffle organization(GO:0031529) |
1.6 | 13.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.6 | 3.2 | GO:0031065 | regulation of histone deacetylation(GO:0031063) positive regulation of histone deacetylation(GO:0031065) |
1.6 | 9.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.6 | 4.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.6 | 1.6 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
1.6 | 3.2 | GO:0016358 | dendrite development(GO:0016358) |
1.6 | 27.4 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
1.6 | 4.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.6 | 1.6 | GO:0048541 | Peyer's patch development(GO:0048541) |
1.6 | 14.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.6 | 6.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.6 | 4.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.6 | 6.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
1.6 | 3.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
1.6 | 9.6 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.6 | 3.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.6 | 1.6 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.6 | 4.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
1.6 | 4.8 | GO:0043627 | response to estrogen(GO:0043627) |
1.6 | 3.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
1.6 | 6.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
1.6 | 6.3 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
1.6 | 36.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
1.6 | 37.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.6 | 3.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.6 | 3.1 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
1.6 | 4.7 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
1.5 | 4.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.5 | 1.5 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
1.5 | 4.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.5 | 1.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.5 | 3.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.5 | 7.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
1.5 | 3.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
1.5 | 4.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.5 | 24.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
1.5 | 33.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.5 | 1.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
1.5 | 6.2 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
1.5 | 3.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
1.5 | 1.5 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
1.5 | 3.1 | GO:0045921 | positive regulation of exocytosis(GO:0045921) positive regulation of regulated secretory pathway(GO:1903307) |
1.5 | 12.3 | GO:0034311 | diol metabolic process(GO:0034311) |
1.5 | 4.6 | GO:0035329 | hippo signaling(GO:0035329) |
1.5 | 1.5 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
1.5 | 4.6 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.5 | 60.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
1.5 | 1.5 | GO:0048478 | replication fork protection(GO:0048478) |
1.5 | 3.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
1.5 | 3.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.5 | 3.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
1.5 | 1.5 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
1.5 | 10.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
1.5 | 4.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
1.5 | 10.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
1.5 | 6.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
1.5 | 4.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
1.5 | 7.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.5 | 6.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.5 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.5 | 6.0 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
1.5 | 1.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
1.5 | 3.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.5 | 3.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.5 | 3.0 | GO:0032060 | bleb assembly(GO:0032060) |
1.5 | 3.0 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
1.5 | 5.9 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.5 | 7.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.5 | 20.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.5 | 5.9 | GO:0080111 | DNA demethylation(GO:0080111) |
1.5 | 7.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.5 | 19.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
1.5 | 4.4 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
1.5 | 5.9 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
1.5 | 5.9 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
1.5 | 1.5 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.5 | 2.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.5 | 39.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.5 | 1.5 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
1.5 | 46.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
1.5 | 1.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.5 | 1.5 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
1.5 | 1.5 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
1.5 | 7.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.5 | 5.8 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
1.5 | 4.4 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
1.5 | 5.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.5 | 2.9 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
1.5 | 11.6 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
1.5 | 2.9 | GO:0010447 | response to acidic pH(GO:0010447) |
1.4 | 2.9 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.4 | 1.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.4 | 2.9 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
1.4 | 5.8 | GO:0031297 | replication fork processing(GO:0031297) |
1.4 | 1.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
1.4 | 7.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.4 | 1.4 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
1.4 | 2.9 | GO:0022616 | DNA strand elongation(GO:0022616) |
1.4 | 14.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
1.4 | 1.4 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
1.4 | 50.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.4 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.4 | 10.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
1.4 | 32.9 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
1.4 | 5.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
1.4 | 5.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.4 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.4 | 7.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.4 | 4.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.4 | 10.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.4 | 8.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.4 | 5.7 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
1.4 | 8.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
1.4 | 12.8 | GO:0016925 | protein sumoylation(GO:0016925) |
1.4 | 4.3 | GO:0002063 | chondrocyte development(GO:0002063) |
1.4 | 4.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
1.4 | 2.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.4 | 8.5 | GO:0006546 | glycine catabolic process(GO:0006546) |
1.4 | 4.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.4 | 4.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.4 | 4.2 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
1.4 | 2.8 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
1.4 | 21.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.4 | 5.6 | GO:0019985 | translesion synthesis(GO:0019985) |
1.4 | 2.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.4 | 4.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.4 | 4.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
1.4 | 5.6 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
1.4 | 4.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.4 | 6.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.4 | 1.4 | GO:0051101 | regulation of DNA binding(GO:0051101) |
1.4 | 28.9 | GO:1903363 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) negative regulation of cellular protein catabolic process(GO:1903363) |
1.4 | 1.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
1.4 | 4.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.4 | 1.4 | GO:0016556 | mRNA modification(GO:0016556) |
1.4 | 5.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.4 | 1.4 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
1.4 | 9.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.4 | 5.5 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.4 | 1.4 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
1.4 | 2.7 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
1.4 | 1.4 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
1.4 | 2.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.4 | 4.1 | GO:0009405 | pathogenesis(GO:0009405) |
1.4 | 2.7 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.4 | 2.7 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
1.4 | 12.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.4 | 2.7 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
1.4 | 10.8 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
1.3 | 10.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.3 | 2.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
1.3 | 1.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
1.3 | 1.3 | GO:0033157 | regulation of intracellular protein transport(GO:0033157) |
1.3 | 4.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.3 | 318.2 | GO:0016568 | chromatin modification(GO:0016568) |
1.3 | 53.7 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.3 | 2.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
1.3 | 4.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.3 | 2.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
1.3 | 1.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
1.3 | 5.4 | GO:0070527 | platelet aggregation(GO:0070527) |
1.3 | 1.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.3 | 9.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.3 | 1.3 | GO:1900181 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
1.3 | 4.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 17.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.3 | 1.3 | GO:0008064 | regulation of actin polymerization or depolymerization(GO:0008064) |
1.3 | 17.3 | GO:0007032 | endosome organization(GO:0007032) |
1.3 | 6.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
1.3 | 9.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.3 | 1.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.3 | 7.9 | GO:0015074 | DNA integration(GO:0015074) |
1.3 | 14.5 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
1.3 | 5.3 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
1.3 | 2.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
1.3 | 2.6 | GO:0017157 | regulation of exocytosis(GO:0017157) |
1.3 | 1.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
1.3 | 2.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.3 | 2.6 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
1.3 | 14.5 | GO:0016180 | snRNA processing(GO:0016180) |
1.3 | 4.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
1.3 | 6.6 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
1.3 | 44.8 | GO:0034341 | response to interferon-gamma(GO:0034341) |
1.3 | 3.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.3 | 13.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
1.3 | 2.6 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
1.3 | 5.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
1.3 | 10.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
1.3 | 32.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.3 | 2.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.3 | 5.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.3 | 5.2 | GO:0032057 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
1.3 | 2.6 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
1.3 | 30.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.3 | 1.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
1.3 | 1.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.3 | 52.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
1.3 | 16.9 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
1.3 | 1.3 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.3 | 9.1 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
1.3 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.3 | 1.3 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
1.3 | 1.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
1.3 | 3.9 | GO:0043631 | RNA polyadenylation(GO:0043631) |
1.3 | 5.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
1.3 | 11.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
1.3 | 3.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.3 | 5.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
1.3 | 2.5 | GO:0070842 | aggresome assembly(GO:0070842) |
1.3 | 5.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.3 | 1.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
1.3 | 3.8 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
1.3 | 5.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.3 | 5.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.3 | 2.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.3 | 6.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.3 | 136.2 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
1.3 | 10.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
1.3 | 8.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
1.3 | 2.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.3 | 3.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
1.2 | 5.0 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
1.2 | 31.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
1.2 | 3.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.2 | 3.7 | GO:0009301 | snRNA transcription(GO:0009301) |
1.2 | 3.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.2 | 6.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.2 | 6.2 | GO:0043248 | proteasome assembly(GO:0043248) |
1.2 | 2.5 | GO:0015749 | monosaccharide transport(GO:0015749) |
1.2 | 1.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.2 | 1.2 | GO:0050773 | regulation of dendrite development(GO:0050773) |
1.2 | 2.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.2 | 6.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
1.2 | 28.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
1.2 | 2.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.2 | 3.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.2 | 3.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
1.2 | 1.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
1.2 | 3.7 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
1.2 | 12.2 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
1.2 | 4.9 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
1.2 | 12.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
1.2 | 3.6 | GO:0001881 | receptor recycling(GO:0001881) |
1.2 | 3.6 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway(GO:0007169) |
1.2 | 3.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
1.2 | 13.4 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
1.2 | 3.6 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
1.2 | 2.4 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
1.2 | 6.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.2 | 3.6 | GO:0030497 | fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation(GO:0030497) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) very long-chain fatty acid biosynthetic process(GO:0042761) |
1.2 | 10.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.2 | 6.0 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.2 | 1.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
1.2 | 1.2 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
1.2 | 2.4 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
1.2 | 2.4 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
1.2 | 6.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.2 | 3.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.2 | 3.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
1.2 | 4.8 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
1.2 | 3.6 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
1.2 | 4.7 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
1.2 | 3.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.2 | 1.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.2 | 4.7 | GO:0006448 | regulation of translational elongation(GO:0006448) |
1.2 | 24.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
1.2 | 5.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
1.2 | 10.6 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
1.2 | 4.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
1.2 | 4.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.2 | 2.3 | GO:0051775 | response to redox state(GO:0051775) |
1.2 | 5.9 | GO:0032613 | interleukin-10 production(GO:0032613) |
1.2 | 122.7 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
1.2 | 4.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.2 | 7.0 | GO:0007041 | lysosomal transport(GO:0007041) |
1.2 | 3.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.2 | 3.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.2 | 1.2 | GO:0045123 | cellular extravasation(GO:0045123) |
1.2 | 1.2 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
1.2 | 2.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.2 | 13.9 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.2 | 17.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.2 | 3.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
1.2 | 8.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.2 | 2.3 | GO:0019042 | viral latency(GO:0019042) |
1.2 | 81.8 | GO:0051028 | mRNA transport(GO:0051028) |
1.2 | 1.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
1.1 | 1.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
1.1 | 3.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
1.1 | 1.1 | GO:0018343 | protein farnesylation(GO:0018343) |
1.1 | 11.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.1 | 3.4 | GO:0044070 | regulation of anion transport(GO:0044070) |
1.1 | 3.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.1 | 70.7 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
1.1 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.1 | 2.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
1.1 | 1.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
1.1 | 5.7 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
1.1 | 3.4 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
1.1 | 1.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
1.1 | 1.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.1 | 2.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
1.1 | 7.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.1 | 2.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 11.2 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
1.1 | 1.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
1.1 | 1.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
1.1 | 2.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
1.1 | 1.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.1 | 111.2 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
1.1 | 2.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
1.1 | 1.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.1 | 3.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
1.1 | 38.8 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
1.1 | 2.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.1 | 6.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.1 | 2.2 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
1.1 | 16.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.1 | 2.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.1 | 1.1 | GO:0043276 | anoikis(GO:0043276) |
1.1 | 3.3 | GO:0001910 | regulation of leukocyte mediated cytotoxicity(GO:0001910) |
1.1 | 11.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.1 | 3.3 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
1.1 | 6.6 | GO:0051597 | response to methylmercury(GO:0051597) |
1.1 | 3.3 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
1.1 | 2.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.1 | 4.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
1.1 | 1.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
1.1 | 4.4 | GO:0007172 | signal complex assembly(GO:0007172) |
1.1 | 8.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.1 | 3.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
1.1 | 4.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.1 | 3.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
1.1 | 10.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
1.1 | 1.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
1.1 | 2.2 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
1.1 | 3.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
1.1 | 3.3 | GO:0060479 | lung cell differentiation(GO:0060479) |
1.1 | 1.1 | GO:0031929 | TOR signaling(GO:0031929) |
1.1 | 3.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.1 | 2.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
1.1 | 1.1 | GO:0006266 | DNA ligation(GO:0006266) |
1.1 | 4.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
1.1 | 16.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.1 | 5.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.1 | 2.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.1 | 1.1 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
1.1 | 3.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.1 | 1.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
1.1 | 30.7 | GO:0007051 | spindle organization(GO:0007051) |
1.1 | 1.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.1 | 30.6 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
1.1 | 9.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.1 | 2.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
1.1 | 1.1 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) negative regulation of T cell mediated immunity(GO:0002710) |
1.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.1 | 2.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
1.1 | 1.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
1.1 | 8.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
1.0 | 9.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.0 | 1.0 | GO:0015851 | nucleobase transport(GO:0015851) |
1.0 | 4.2 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
1.0 | 1.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.0 | 2.1 | GO:0051301 | cell division(GO:0051301) |
1.0 | 1.0 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
1.0 | 3.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
1.0 | 15.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
1.0 | 4.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.0 | 2.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.0 | 7.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
1.0 | 3.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
1.0 | 2.1 | GO:0006298 | mismatch repair(GO:0006298) |
1.0 | 2.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
1.0 | 5.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.0 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.0 | 2.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.0 | 4.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
1.0 | 3.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.0 | 10.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
1.0 | 25.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
1.0 | 4.0 | GO:0010107 | potassium ion import(GO:0010107) |
1.0 | 1.0 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) regulation of DNA-templated transcription, initiation(GO:2000142) |
1.0 | 4.0 | GO:0046618 | drug export(GO:0046618) |
1.0 | 3.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.0 | 12.0 | GO:0019079 | viral genome replication(GO:0019079) |
1.0 | 5.0 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
1.0 | 26.1 | GO:0006302 | double-strand break repair(GO:0006302) |
1.0 | 1.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.0 | 3.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.0 | 4.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.0 | 1.0 | GO:0019724 | B cell mediated immunity(GO:0019724) |
1.0 | 2.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.0 | 2.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.0 | 2.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.0 | 3.0 | GO:0006862 | nucleotide transport(GO:0006862) |
1.0 | 2.0 | GO:0032606 | type I interferon production(GO:0032606) |
1.0 | 9.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.0 | 3.0 | GO:0042100 | B cell proliferation(GO:0042100) |
1.0 | 4.9 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.0 | 12.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
1.0 | 1.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.0 | 3.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.0 | 1.0 | GO:0007492 | endoderm development(GO:0007492) |
1.0 | 61.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
1.0 | 2.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.0 | 3.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.0 | 3.9 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
1.0 | 4.9 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
1.0 | 6.8 | GO:0051168 | nuclear export(GO:0051168) |
1.0 | 1.0 | GO:0048664 | neuron fate determination(GO:0048664) |
1.0 | 1.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
1.0 | 20.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
1.0 | 10.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.0 | 1.9 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.0 | 1.9 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
1.0 | 7.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.0 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
1.0 | 14.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.0 | 1.9 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.0 | 1.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
1.0 | 4.8 | GO:0031648 | protein destabilization(GO:0031648) |
1.0 | 5.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.0 | 2.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.0 | 93.1 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) |
1.0 | 3.8 | GO:1901678 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
1.0 | 4.8 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
1.0 | 64.1 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
1.0 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
1.0 | 12.4 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.0 | 2.9 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
1.0 | 5.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.9 | 1.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.9 | 11.4 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.9 | 1.9 | GO:0001709 | cell fate determination(GO:0001709) |
0.9 | 3.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.9 | 4.7 | GO:0003016 | respiratory system process(GO:0003016) |
0.9 | 2.8 | GO:0016445 | somatic diversification of immune receptors(GO:0002200) somatic diversification of immunoglobulins(GO:0016445) |
0.9 | 1.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.9 | 1.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.9 | 1.9 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.9 | 3.7 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.9 | 3.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.9 | 9.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.9 | 6.5 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.9 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.9 | 2.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.9 | 0.9 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.9 | 16.6 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.9 | 85.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.9 | 2.7 | GO:0021754 | facial nucleus development(GO:0021754) |
0.9 | 1.8 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.9 | 2.7 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.9 | 28.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.9 | 3.6 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.9 | 4.5 | GO:0051298 | centrosome duplication(GO:0051298) |
0.9 | 0.9 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.9 | 1.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.9 | 0.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.9 | 2.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 0.9 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.9 | 4.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.9 | 13.4 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.9 | 1.8 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.9 | 7.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.9 | 0.9 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.9 | 8.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.9 | 4.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.9 | 1.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.9 | 1.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.9 | 2.7 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.9 | 1.8 | GO:0031638 | zymogen activation(GO:0031638) |
0.9 | 2.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.9 | 12.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.9 | 3.5 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.9 | 1.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.9 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.9 | 3.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.9 | 3.5 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.9 | 19.1 | GO:0006396 | RNA processing(GO:0006396) |
0.9 | 1.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 5.2 | GO:0030903 | notochord development(GO:0030903) |
0.9 | 1.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.9 | 2.6 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.9 | 1.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.9 | 1.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.9 | 4.3 | GO:0043090 | amino acid import(GO:0043090) |
0.9 | 23.8 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.9 | 3.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.9 | 2.6 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.8 | 0.8 | GO:0033683 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) nucleotide-excision repair, DNA incision(GO:0033683) |
0.8 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.8 | 0.8 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.8 | 2.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.8 | 4.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.8 | 1.7 | GO:0035094 | response to nicotine(GO:0035094) |
0.8 | 0.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.8 | 0.8 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.8 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.8 | 4.2 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.8 | 1.7 | GO:0007031 | peroxisome organization(GO:0007031) |
0.8 | 0.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.8 | 5.0 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.8 | 3.4 | GO:0007568 | aging(GO:0007568) |
0.8 | 4.2 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.8 | 0.8 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.8 | 1.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.8 | 2.5 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
0.8 | 3.3 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.8 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.8 | 2.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.8 | 2.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.8 | 9.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.8 | 7.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.8 | 1.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.8 | 7.4 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.8 | 0.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.8 | 4.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.8 | 4.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.8 | 73.8 | GO:0006457 | protein folding(GO:0006457) |
0.8 | 5.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.8 | 44.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.8 | 3.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.8 | 2.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.8 | 0.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.8 | 4.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 47.3 | GO:0006415 | translational termination(GO:0006415) |
0.8 | 26.1 | GO:0009185 | ribonucleoside diphosphate metabolic process(GO:0009185) |
0.8 | 33.3 | GO:0006413 | translational initiation(GO:0006413) |
0.8 | 68.2 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.8 | 0.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.8 | 1.6 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.8 | 21.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.8 | 8.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.8 | 21.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.8 | 1.6 | GO:0097553 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.8 | 10.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.8 | 2.4 | GO:0009310 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.8 | 10.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.8 | 3.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 1.6 | GO:0008049 | male courtship behavior(GO:0008049) |
0.8 | 1.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.8 | 4.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.8 | 2.4 | GO:0000239 | pachytene(GO:0000239) |
0.8 | 2.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.8 | 0.8 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.8 | 1.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 2.4 | GO:0003300 | cardiac muscle hypertrophy(GO:0003300) striated muscle hypertrophy(GO:0014897) |
0.8 | 53.3 | GO:0016032 | viral process(GO:0016032) |
0.8 | 5.5 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.8 | 3.9 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.8 | 3.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.8 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.8 | 7.0 | GO:0006260 | DNA replication(GO:0006260) |
0.8 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.8 | 1.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.8 | 1.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.8 | 3.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.8 | 2.3 | GO:0043241 | protein complex disassembly(GO:0043241) |
0.8 | 2.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.8 | 0.8 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.8 | 2.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.8 | 2.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.8 | 3.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.8 | 7.7 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.8 | 3.8 | GO:0030323 | respiratory tube development(GO:0030323) |
0.8 | 44.8 | GO:0031497 | chromatin assembly(GO:0031497) |
0.8 | 1.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.8 | 4.5 | GO:0000050 | urea cycle(GO:0000050) |
0.8 | 9.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.8 | 9.1 | GO:0006414 | translational elongation(GO:0006414) |
0.8 | 1.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.8 | 10.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.8 | 5.3 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.8 | 2.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.8 | 3.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.7 | 0.7 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.7 | 0.7 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.7 | 4.5 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.7 | 0.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.7 | 0.7 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.7 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 1.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 0.7 | GO:0048532 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.7 | 1.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.7 | 1.5 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.7 | 1.5 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.7 | 10.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.7 | 23.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.7 | 0.7 | GO:0001832 | blastocyst growth(GO:0001832) |
0.7 | 1.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 1.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.7 | 4.4 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.7 | 0.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.7 | 5.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.7 | 2.9 | GO:0046689 | response to mercury ion(GO:0046689) |
0.7 | 8.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.7 | 18.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.7 | 0.7 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.7 | 38.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.7 | 0.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.7 | 6.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.7 | 14.4 | GO:0000910 | cytokinesis(GO:0000910) |
0.7 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.7 | 2.9 | GO:0000279 | M phase(GO:0000279) |
0.7 | 1.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.7 | 2.9 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.7 | 12.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.7 | 2.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 4.3 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.7 | 16.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.7 | 0.7 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.7 | 0.7 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.7 | 5.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.7 | 0.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 2.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.7 | 19.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.7 | 1.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 2.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 4.9 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.7 | 8.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.7 | 3.5 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.7 | 5.5 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.7 | 4.8 | GO:0007632 | visual behavior(GO:0007632) |
0.7 | 24.1 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.7 | 0.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.7 | 1.4 | GO:0048535 | lymph node development(GO:0048535) |
0.7 | 2.1 | GO:0006325 | chromatin organization(GO:0006325) |
0.7 | 5.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.7 | 2.0 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.7 | 0.7 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.7 | 1.4 | GO:0007343 | egg activation(GO:0007343) |
0.7 | 22.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.7 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.7 | 1.4 | GO:0002685 | regulation of leukocyte migration(GO:0002685) |
0.7 | 2.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.7 | 3.4 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.7 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.7 | 0.7 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.7 | 1.3 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.7 | 2.7 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.7 | 6.6 | GO:0040013 | negative regulation of locomotion(GO:0040013) |
0.7 | 4.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.7 | 29.7 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.7 | 1.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.7 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.7 | 0.7 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.7 | 7.2 | GO:0043604 | amide biosynthetic process(GO:0043604) |
0.7 | 3.3 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.7 | 2.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.7 | 2.6 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.6 | 10.4 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.6 | 0.6 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.6 | 1.9 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.6 | 1.3 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.6 | 1.3 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.6 | 1.9 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.6 | 2.6 | GO:0009100 | glycoprotein metabolic process(GO:0009100) |
0.6 | 2.6 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.6 | 1.9 | GO:0045008 | depyrimidination(GO:0045008) |
0.6 | 5.1 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.6 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.6 | 1.3 | GO:0007612 | learning(GO:0007612) |
0.6 | 0.6 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.6 | 31.0 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.6 | 18.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 2.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 7.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.6 | 10.6 | GO:0007286 | spermatid development(GO:0007286) |
0.6 | 1.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.6 | 1.2 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.6 | 1.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.6 | 12.5 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.6 | 19.3 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.6 | 1.9 | GO:0070486 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.6 | 21.7 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.6 | 3.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.6 | 3.7 | GO:0003407 | neural retina development(GO:0003407) |
0.6 | 1.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.6 | 5.6 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.6 | 1.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.6 | 15.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 0.6 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.6 | 0.6 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.6 | 3.0 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.6 | 3.6 | GO:0009101 | glycoprotein biosynthetic process(GO:0009101) |
0.6 | 1.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.6 | 0.6 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.6 | 1.2 | GO:0007140 | male meiosis(GO:0007140) |
0.6 | 14.5 | GO:0006909 | phagocytosis(GO:0006909) |
0.6 | 0.6 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.6 | 49.9 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.6 | 6.0 | GO:0016236 | macroautophagy(GO:0016236) |
0.6 | 0.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.6 | 11.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.6 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 0.6 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.6 | 0.6 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.6 | 2.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.6 | 1.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.6 | 2.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.6 | 0.6 | GO:0055081 | anion homeostasis(GO:0055081) |
0.6 | 1.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.6 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.6 | 1.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.6 | 1.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.6 | 6.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.6 | 71.0 | GO:0006412 | translation(GO:0006412) |
0.6 | 1.7 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.6 | 1.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.6 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 3.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.6 | 0.6 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.6 | 5.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.6 | 2.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 9.0 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.6 | 3.4 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.6 | 3.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 627.9 | GO:0097659 | transcription, DNA-templated(GO:0006351) nucleic acid-templated transcription(GO:0097659) |
0.6 | 5.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) ERBB signaling pathway(GO:0038127) |
0.6 | 1.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.6 | 1.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.6 | 1.1 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.6 | 2.2 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.6 | 18.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.6 | 5.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.6 | 1.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.6 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 0.6 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.6 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 0.5 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 2.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.5 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 1.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.5 | 1.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.5 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.5 | 3.3 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.5 | 12.5 | GO:0007602 | phototransduction(GO:0007602) |
0.5 | 2.7 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.5 | 39.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.5 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.5 | 2.1 | GO:0007389 | pattern specification process(GO:0007389) |
0.5 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.5 | 1.1 | GO:0015992 | proton transport(GO:0015992) |
0.5 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.5 | 2.1 | GO:0002009 | morphogenesis of an epithelium(GO:0002009) |
0.5 | 11.6 | GO:0001525 | angiogenesis(GO:0001525) |
0.5 | 10.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.5 | 10.5 | GO:0009966 | regulation of signal transduction(GO:0009966) |
0.5 | 1.0 | GO:0071599 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.5 | 2.1 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.5 | 0.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.5 | 2.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.5 | 1.5 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.5 | 0.5 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.5 | 1.0 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.5 | 1.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.5 | 1.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.5 | 1.0 | GO:0044724 | single-organism carbohydrate catabolic process(GO:0044724) |
0.5 | 0.5 | GO:0009612 | response to mechanical stimulus(GO:0009612) |
0.5 | 1.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.5 | 4.5 | GO:0032259 | methylation(GO:0032259) |
0.5 | 0.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.5 | 8.0 | GO:0001906 | cell killing(GO:0001906) |
0.5 | 5.5 | GO:0016310 | phosphorylation(GO:0016310) |
0.5 | 5.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.5 | 0.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.5 | 5.0 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.5 | 0.5 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
0.5 | 7.9 | GO:0006914 | autophagy(GO:0006914) |
0.5 | 2.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.5 | 1.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.5 | 16.6 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.5 | 20.4 | GO:0007517 | muscle organ development(GO:0007517) |
0.5 | 1.0 | GO:0001570 | vasculogenesis(GO:0001570) |
0.5 | 4.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.5 | 4.3 | GO:0050821 | protein stabilization(GO:0050821) |
0.5 | 5.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.5 | 9.6 | GO:0016197 | endosomal transport(GO:0016197) |
0.5 | 5.7 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.5 | 1.0 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.5 | 4.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.5 | 1.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.5 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.5 | 0.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.5 | 7.0 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.5 | 3.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 6.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.5 | 86.0 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.5 | 0.9 | GO:0033554 | cellular response to stress(GO:0033554) |
0.5 | 19.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.5 | 2.3 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) regulation of oxidoreductase activity(GO:0051341) |
0.5 | 0.9 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.5 | 6.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.5 | 4.6 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.5 | 0.5 | GO:0045471 | response to ethanol(GO:0045471) |
0.5 | 0.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.5 | 1.4 | GO:0071103 | DNA conformation change(GO:0071103) |
0.5 | 5.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.4 | 1.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.4 | 0.4 | GO:0060485 | mesenchyme development(GO:0060485) |
0.4 | 1.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 0.9 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 0.9 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.4 | 34.7 | GO:0035556 | intracellular signal transduction(GO:0035556) |
0.4 | 2.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 0.4 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.4 | 4.3 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 2.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.4 | 93.0 | GO:0015031 | protein transport(GO:0015031) |
0.4 | 1.3 | GO:0015840 | urea transport(GO:0015840) |
0.4 | 3.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.4 | 1.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.4 | 5.5 | GO:0030163 | protein catabolic process(GO:0030163) |
0.4 | 6.3 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.4 | 3.8 | GO:0007588 | excretion(GO:0007588) |
0.4 | 6.3 | GO:1903047 | mitotic cell cycle process(GO:1903047) |
0.4 | 0.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.4 | 1.7 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.4 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.4 | 1.2 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 6.1 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.4 | 3.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 2.0 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.4 | 0.4 | GO:0060840 | artery development(GO:0060840) |
0.4 | 1.6 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.4 | 4.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 2.3 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.4 | 0.8 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 2.3 | GO:0031102 | neuron projection regeneration(GO:0031102) axon regeneration(GO:0031103) |
0.4 | 0.8 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.4 | 0.4 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.4 | 1.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 3.4 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.4 | 0.8 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
0.4 | 0.4 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.4 | 0.4 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 1.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 2.3 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.4 | 3.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.4 | 11.2 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.4 | 1.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 7.8 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.4 | 3.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 1.8 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.4 | 0.7 | GO:0007398 | ectoderm development(GO:0007398) |
0.4 | 0.7 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.4 | 0.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.4 | 0.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 1.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.4 | 0.4 | GO:0051262 | protein tetramerization(GO:0051262) |
0.4 | 0.7 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.4 | 6.8 | GO:0010038 | response to metal ion(GO:0010038) |
0.4 | 0.7 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.4 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 20.8 | GO:0006869 | lipid transport(GO:0006869) |
0.4 | 0.7 | GO:0051783 | regulation of nuclear division(GO:0051783) |
0.4 | 2.8 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.3 | 0.3 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.3 | 0.7 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.3 | 1.0 | GO:0006833 | water transport(GO:0006833) |
0.3 | 0.7 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.3 | 0.3 | GO:0051053 | negative regulation of DNA replication(GO:0008156) negative regulation of DNA metabolic process(GO:0051053) |
0.3 | 0.7 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.3 | 3.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 4.7 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.3 | 2.0 | GO:0034762 | regulation of transmembrane transport(GO:0034762) regulation of ion transmembrane transport(GO:0034765) |
0.3 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 3.3 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.3 | 1.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.3 | GO:0021675 | nerve development(GO:0021675) |
0.3 | 1.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.3 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 1.0 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.3 | 1.0 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 6.4 | GO:0030097 | hemopoiesis(GO:0030097) |
0.3 | 1.0 | GO:0030810 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
0.3 | 1.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 1.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 3.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.3 | 1.6 | GO:0009451 | RNA modification(GO:0009451) |
0.3 | 2.5 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
0.3 | 2.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.3 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.9 | GO:0043473 | pigmentation(GO:0043473) |
0.3 | 0.3 | GO:0060119 | inner ear receptor cell development(GO:0060119) inner ear receptor stereocilium organization(GO:0060122) |
0.3 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.3 | GO:0048588 | developmental cell growth(GO:0048588) |
0.3 | 0.9 | GO:0051297 | centrosome organization(GO:0051297) |
0.3 | 0.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 1.2 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.3 | 9.3 | GO:0006281 | DNA repair(GO:0006281) |
0.3 | 2.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 2.4 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.3 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 0.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.3 | 0.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 9.8 | GO:0006887 | exocytosis(GO:0006887) |
0.3 | 0.3 | GO:0010876 | lipid localization(GO:0010876) |
0.3 | 59.2 | GO:0006915 | apoptotic process(GO:0006915) |
0.3 | 0.6 | GO:1990778 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.3 | 1.7 | GO:0001701 | in utero embryonic development(GO:0001701) |
0.3 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 3.9 | GO:0006816 | calcium ion transport(GO:0006816) |
0.3 | 0.8 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.3 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 0.8 | GO:0051591 | response to cAMP(GO:0051591) |
0.3 | 1.1 | GO:0022404 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.3 | 2.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 1.6 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.3 | 8.3 | GO:0008219 | cell death(GO:0008219) |
0.3 | 0.3 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 3.4 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 15.8 | GO:0040007 | growth(GO:0040007) |
0.3 | 1.3 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.3 | 73.6 | GO:0006508 | proteolysis(GO:0006508) |
0.3 | 0.3 | GO:0009582 | detection of abiotic stimulus(GO:0009582) |
0.3 | 5.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 2.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 22.9 | GO:0050817 | coagulation(GO:0050817) |
0.3 | 0.5 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.3 | 1.5 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.2 | 0.7 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.2 | 0.2 | GO:0072175 | epithelial tube formation(GO:0072175) |
0.2 | 0.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 2.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.2 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.2 | 0.5 | GO:0042455 | ribonucleoside biosynthetic process(GO:0042455) |
0.2 | 0.9 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.2 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.2 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.2 | 1.5 | GO:0072330 | monocarboxylic acid biosynthetic process(GO:0072330) |
0.2 | 3.6 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 0.2 | GO:0021543 | pallium development(GO:0021543) |
0.2 | 2.1 | GO:0048583 | regulation of response to stimulus(GO:0048583) |
0.2 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0032615 | interleukin-12 production(GO:0032615) |
0.2 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) plasma membrane fusion(GO:0045026) |
0.2 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.2 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.2 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.2 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.2 | 0.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 7.1 | GO:0016192 | vesicle-mediated transport(GO:0016192) |
0.2 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 2.1 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.2 | 36.5 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.2 | 1.3 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
0.2 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 2.3 | GO:0016477 | cell migration(GO:0016477) |
0.2 | 3.4 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.2 | 10.0 | GO:0007049 | cell cycle(GO:0007049) |
0.2 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.3 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.2 | 1.5 | GO:0010467 | gene expression(GO:0010467) |
0.2 | 0.2 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.2 | 0.2 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.2 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
0.2 | 38.0 | GO:0044267 | cellular protein metabolic process(GO:0044267) |
0.2 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 5.5 | GO:0006950 | response to stress(GO:0006950) |
0.2 | 1.1 | GO:0007631 | feeding behavior(GO:0007631) |
0.1 | 1.3 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.1 | 0.1 | GO:1903522 | regulation of blood circulation(GO:1903522) |
0.1 | 0.1 | GO:0007548 | sex differentiation(GO:0007548) |
0.1 | 0.6 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.6 | GO:0009266 | response to temperature stimulus(GO:0009266) |
0.1 | 1.0 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.1 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 1.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.1 | GO:0010256 | endomembrane system organization(GO:0010256) |
0.1 | 0.1 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 1.2 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 3.4 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 2.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) neuronal action potential propagation(GO:0019227) multicellular organismal signaling(GO:0035637) action potential propagation(GO:0098870) |
0.1 | 1.8 | GO:0009887 | organ morphogenesis(GO:0009887) |
0.1 | 3.0 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 9.5 | GO:0008152 | metabolic process(GO:0008152) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 7.8 | GO:0007276 | gamete generation(GO:0007276) |
0.1 | 0.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 1.2 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.1 | 1.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.1 | GO:0060993 | kidney morphogenesis(GO:0060993) |
0.1 | 0.2 | GO:0007507 | heart development(GO:0007507) |
0.1 | 0.5 | GO:0090257 | regulation of muscle system process(GO:0090257) |
0.1 | 1.3 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 3.2 | GO:0009607 | response to biotic stimulus(GO:0009607) |
0.1 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.9 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.1 | 0.3 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.1 | 2.2 | GO:0005975 | carbohydrate metabolic process(GO:0005975) |
0.1 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.1 | 0.1 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.5 | GO:0042493 | response to drug(GO:0042493) |
0.0 | 0.6 | GO:0042127 | regulation of cell proliferation(GO:0042127) |
0.0 | 0.2 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.0 | GO:0051924 | regulation of calcium ion transport(GO:0051924) |
0.0 | 0.1 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.1 | GO:0044802 | single-organism membrane organization(GO:0044802) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 2.4 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.6 | GO:0006082 | organic acid metabolic process(GO:0006082) |
0.0 | 0.3 | GO:0009636 | response to toxic substance(GO:0009636) |
0.0 | 0.0 | GO:0001101 | response to acid chemical(GO:0001101) |
0.0 | 0.0 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.0 | 2.1 | GO:0006629 | lipid metabolic process(GO:0006629) |
0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.1 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0042552 | myelination(GO:0042552) |
0.0 | 9.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0001655 | urogenital system development(GO:0001655) |
0.0 | 7.3 | GO:0007154 | cell communication(GO:0007154) |
0.0 | 7.5 | GO:0006810 | transport(GO:0006810) |
0.0 | 0.3 | GO:0065003 | macromolecular complex assembly(GO:0065003) |
0.0 | 0.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 19.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.6 | 10.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.5 | 14.2 | GO:0005827 | polar microtubule(GO:0005827) |
3.4 | 3.4 | GO:0005694 | chromosome(GO:0005694) |
3.3 | 9.9 | GO:0072487 | MSL complex(GO:0072487) |
3.3 | 9.9 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
3.2 | 12.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
3.1 | 18.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
3.1 | 12.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
3.1 | 6.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
2.7 | 13.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.7 | 8.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.7 | 10.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.5 | 2.5 | GO:0070938 | contractile ring(GO:0070938) |
2.5 | 9.9 | GO:0070820 | tertiary granule(GO:0070820) |
2.5 | 7.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.5 | 24.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.4 | 7.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
2.3 | 9.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.3 | 15.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
2.2 | 38.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
2.2 | 11.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
2.2 | 6.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.2 | 6.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.2 | 8.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
2.2 | 10.9 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
2.2 | 6.5 | GO:0048179 | activin receptor complex(GO:0048179) |
2.2 | 17.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.2 | 6.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
2.1 | 8.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
2.1 | 6.4 | GO:0000124 | SAGA complex(GO:0000124) |
2.1 | 17.2 | GO:0071564 | npBAF complex(GO:0071564) |
2.1 | 19.1 | GO:0042555 | MCM complex(GO:0042555) |
2.1 | 40.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.1 | 2.1 | GO:0045178 | basal part of cell(GO:0045178) |
2.1 | 6.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
2.1 | 14.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.0 | 8.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
2.0 | 18.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
2.0 | 6.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.0 | 10.1 | GO:0038201 | TOR complex(GO:0038201) |
2.0 | 23.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.0 | 5.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
2.0 | 5.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.9 | 3.9 | GO:0032449 | CBM complex(GO:0032449) |
1.9 | 11.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.9 | 9.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.9 | 7.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.9 | 17.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.9 | 5.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.9 | 5.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.8 | 35.0 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
1.8 | 16.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.8 | 41.6 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
1.8 | 5.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.8 | 10.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.8 | 1.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.8 | 10.6 | GO:0005682 | U5 snRNP(GO:0005682) |
1.8 | 8.8 | GO:0070695 | FHF complex(GO:0070695) |
1.7 | 8.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.7 | 5.2 | GO:0000792 | heterochromatin(GO:0000792) |
1.7 | 36.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.7 | 13.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
1.7 | 13.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
1.7 | 13.7 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
1.7 | 5.1 | GO:0016939 | kinesin II complex(GO:0016939) |
1.7 | 13.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
1.7 | 11.8 | GO:0051233 | spindle midzone(GO:0051233) |
1.7 | 21.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.7 | 8.3 | GO:0005652 | nuclear lamina(GO:0005652) |
1.7 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
1.6 | 9.9 | GO:0042382 | paraspeckles(GO:0042382) |
1.6 | 4.9 | GO:0032009 | early phagosome(GO:0032009) |
1.6 | 4.8 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.6 | 8.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 58.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.6 | 9.5 | GO:0002102 | podosome(GO:0002102) |
1.6 | 9.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.6 | 4.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.6 | 18.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.6 | 6.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.6 | 17.1 | GO:0001772 | immunological synapse(GO:0001772) |
1.6 | 4.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.5 | 4.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.5 | 16.9 | GO:0031519 | PcG protein complex(GO:0031519) |
1.5 | 16.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.5 | 3.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.5 | 18.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.5 | 15.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 22.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.5 | 4.5 | GO:0031904 | endosome lumen(GO:0031904) |
1.5 | 4.5 | GO:0034464 | BBSome(GO:0034464) |
1.5 | 6.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
1.5 | 47.7 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
1.5 | 7.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.5 | 4.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 19.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.5 | 4.5 | GO:0071986 | Ragulator complex(GO:0071986) |
1.5 | 99.3 | GO:0005643 | nuclear pore(GO:0005643) |
1.5 | 29.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.5 | 44.2 | GO:0016592 | mediator complex(GO:0016592) |
1.5 | 2.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.5 | 8.8 | GO:0031528 | microvillus membrane(GO:0031528) |
1.5 | 4.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.5 | 8.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 1.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
1.5 | 7.3 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
1.4 | 10.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.4 | 1.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
1.4 | 5.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.4 | 8.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.4 | 26.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.4 | 2.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.4 | 124.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.4 | 25.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.4 | 23.7 | GO:0032420 | stereocilium(GO:0032420) |
1.4 | 12.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
1.4 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.4 | 5.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.4 | 12.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
1.4 | 8.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.3 | 12.1 | GO:0030914 | STAGA complex(GO:0030914) |
1.3 | 5.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
1.3 | 5.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.3 | 5.3 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
1.3 | 7.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.3 | 5.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.3 | 7.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
1.3 | 7.8 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.3 | 6.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.3 | 1.3 | GO:0010369 | chromocenter(GO:0010369) |
1.3 | 3.9 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
1.3 | 3.9 | GO:0030891 | VCB complex(GO:0030891) |
1.3 | 1.3 | GO:0043198 | dendritic shaft(GO:0043198) |
1.3 | 3.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
1.3 | 7.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.3 | 9.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.3 | 28.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.3 | 6.4 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
1.3 | 10.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.3 | 15.2 | GO:0032039 | integrator complex(GO:0032039) |
1.3 | 3.8 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 63.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.3 | 62.9 | GO:0016363 | nuclear matrix(GO:0016363) |
1.3 | 6.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.3 | 25.1 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
1.2 | 2.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.2 | 19.9 | GO:0005871 | kinesin complex(GO:0005871) |
1.2 | 3.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.2 | 1.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
1.2 | 1.2 | GO:0042827 | platelet dense granule(GO:0042827) |
1.2 | 1.2 | GO:0042641 | actomyosin(GO:0042641) |
1.2 | 25.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.2 | 3.7 | GO:0032059 | bleb(GO:0032059) |
1.2 | 7.3 | GO:0016342 | catenin complex(GO:0016342) |
1.2 | 2.4 | GO:0019867 | outer membrane(GO:0019867) |
1.2 | 3.6 | GO:0034399 | nuclear periphery(GO:0034399) |
1.2 | 42.3 | GO:0030496 | midbody(GO:0030496) |
1.2 | 4.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 3.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.2 | 3.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.2 | 4.8 | GO:0016600 | flotillin complex(GO:0016600) |
1.2 | 1.2 | GO:0042611 | MHC protein complex(GO:0042611) |
1.2 | 10.7 | GO:0071203 | WASH complex(GO:0071203) |
1.2 | 28.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.2 | 8.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.2 | 7.1 | GO:0001741 | XY body(GO:0001741) |
1.2 | 8.3 | GO:0000145 | exocyst(GO:0000145) |
1.2 | 18.9 | GO:0031201 | SNARE complex(GO:0031201) |
1.2 | 2.3 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
1.2 | 41.1 | GO:0000922 | spindle pole(GO:0000922) |
1.2 | 18.7 | GO:0005844 | polysome(GO:0005844) |
1.2 | 4.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.2 | 112.7 | GO:0016607 | nuclear speck(GO:0016607) |
1.2 | 10.4 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
1.1 | 16.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.1 | 2.3 | GO:0005876 | spindle microtubule(GO:0005876) |
1.1 | 5.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.1 | 11.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.1 | 4.5 | GO:0005869 | dynactin complex(GO:0005869) |
1.1 | 82.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.1 | 6.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.1 | 5.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.1 | 1.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
1.1 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
1.1 | 3.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.1 | 49.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.1 | 3.3 | GO:0070545 | PeBoW complex(GO:0070545) |
1.1 | 4.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 44.3 | GO:0055037 | recycling endosome(GO:0055037) |
1.1 | 38.6 | GO:0000776 | kinetochore(GO:0000776) |
1.1 | 3.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.1 | 2.2 | GO:0030120 | vesicle coat(GO:0030120) |
1.1 | 3.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.1 | 5.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.1 | 28.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.1 | 3.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.1 | 16.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
1.1 | 6.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.1 | 1.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.1 | 39.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.1 | 44.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.1 | 1.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.1 | 4.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.1 | 45.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.1 | 2.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 8.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.1 | 9.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.1 | 4.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 5.3 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 82.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.1 | 17.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.1 | 38.9 | GO:0016605 | PML body(GO:0016605) |
1.0 | 25.2 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
1.0 | 83.7 | GO:0031965 | nuclear membrane(GO:0031965) |
1.0 | 7.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.0 | 46.8 | GO:0000502 | proteasome complex(GO:0000502) |
1.0 | 5.2 | GO:0008091 | spectrin(GO:0008091) |
1.0 | 12.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
1.0 | 33.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
1.0 | 82.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
1.0 | 92.4 | GO:0005769 | early endosome(GO:0005769) |
1.0 | 4.1 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 2.0 | GO:0032432 | actin filament bundle(GO:0032432) |
1.0 | 3.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.0 | 7.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.0 | 6.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.0 | 105.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.0 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
1.0 | 10.9 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
1.0 | 2.0 | GO:0070552 | BRISC complex(GO:0070552) |
1.0 | 1.9 | GO:0001652 | granular component(GO:0001652) |
1.0 | 4.9 | GO:0000346 | transcription export complex(GO:0000346) |
1.0 | 4.9 | GO:0005883 | neurofilament(GO:0005883) |
1.0 | 8.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.0 | 33.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.0 | 87.6 | GO:0000785 | chromatin(GO:0000785) |
1.0 | 327.3 | GO:0005654 | nucleoplasm(GO:0005654) |
1.0 | 37.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.9 | 714.3 | GO:0005730 | nucleolus(GO:0005730) |
0.9 | 2.8 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.9 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.9 | 18.0 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.9 | 7.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.9 | 1.9 | GO:0031430 | M band(GO:0031430) |
0.9 | 33.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.9 | 13.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.9 | 19.5 | GO:0005819 | spindle(GO:0005819) |
0.9 | 7.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.9 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 8.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.9 | 9.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.9 | 2.7 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.9 | 6.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.9 | 47.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.9 | 2.6 | GO:0016234 | inclusion body(GO:0016234) |
0.9 | 5.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.9 | 2.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.9 | 2.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.9 | 19.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.9 | 3.5 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.9 | 2.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 0.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.9 | 945.5 | GO:0005829 | cytosol(GO:0005829) |
0.9 | 38.4 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.8 | 1974.1 | GO:0005634 | nucleus(GO:0005634) |
0.8 | 9.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.8 | 5.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.8 | 14.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.8 | 30.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.8 | 5.7 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.8 | 31.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.8 | 4.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.8 | 6.2 | GO:0012505 | endomembrane system(GO:0012505) |
0.8 | 0.8 | GO:0043679 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
0.8 | 6.1 | GO:0005840 | ribosome(GO:0005840) |
0.8 | 3.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.8 | 15.2 | GO:0005922 | connexon complex(GO:0005922) |
0.8 | 7.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.8 | 3.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.7 | 1.5 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.7 | 1.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 2.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.7 | 37.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 433.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.7 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
0.7 | 2.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 19.6 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 4.2 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 3.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.7 | 1.4 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.7 | 32.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 22.0 | GO:0034774 | vesicle lumen(GO:0031983) secretory granule lumen(GO:0034774) |
0.7 | 63.7 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.6 | 4.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.6 | 225.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.6 | 32.4 | GO:0005768 | endosome(GO:0005768) |
0.6 | 1.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 5.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 5.1 | GO:0031514 | motile cilium(GO:0031514) |
0.5 | 25.8 | GO:0031252 | cell leading edge(GO:0031252) |
0.5 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 2.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.5 | 4.5 | GO:0030018 | Z disc(GO:0030018) |
0.5 | 5.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.5 | 17.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.5 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 128.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.5 | 2.4 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.5 | 1.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 3.8 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 2.8 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 3.6 | GO:0045202 | synapse(GO:0045202) |
0.4 | 0.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 9.0 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.4 | 22.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 0.8 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.4 | 0.4 | GO:0030684 | preribosome(GO:0030684) |
0.4 | 2.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 1.6 | GO:0033011 | perinuclear theca(GO:0033011) |
0.4 | 1.6 | GO:0044422 | organelle part(GO:0044422) |
0.4 | 0.4 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 6.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 677.9 | GO:0005622 | intracellular(GO:0005622) |
0.4 | 3.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 5.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.0 | GO:0005792 | obsolete microsome(GO:0005792) |
0.3 | 7.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 2.2 | GO:0005912 | adherens junction(GO:0005912) |
0.3 | 0.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.3 | 9.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 1.1 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.3 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 24.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.2 | 524.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.2 | GO:0044304 | main axon(GO:0044304) |
0.2 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.2 | GO:0043227 | membrane-bounded organelle(GO:0043227) |
0.2 | 1.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.1 | GO:1990777 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 1.3 | GO:0043226 | organelle(GO:0043226) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 3.2 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 11.6 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.0 | GO:0005911 | cell-cell junction(GO:0005911) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 8.6 | GO:0070061 | fructose binding(GO:0070061) |
4.0 | 12.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
3.8 | 11.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
3.6 | 14.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
3.6 | 14.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
3.6 | 10.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
3.5 | 14.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.5 | 14.0 | GO:0030911 | TPR domain binding(GO:0030911) |
3.2 | 16.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.2 | 9.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.1 | 18.7 | GO:0005521 | lamin binding(GO:0005521) |
3.1 | 9.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
3.0 | 12.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.9 | 8.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.9 | 11.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.9 | 2.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
2.8 | 17.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
2.8 | 8.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.7 | 8.2 | GO:0005113 | patched binding(GO:0005113) |
2.7 | 8.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.7 | 8.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
2.6 | 13.2 | GO:0015288 | porin activity(GO:0015288) |
2.6 | 7.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.6 | 7.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.6 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.6 | 2.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.6 | 15.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
2.6 | 7.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.6 | 10.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.6 | 7.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
2.5 | 7.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.5 | 5.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
2.5 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
2.4 | 9.8 | GO:0051425 | PTB domain binding(GO:0051425) |
2.4 | 9.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
2.4 | 7.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.4 | 4.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
2.4 | 14.6 | GO:0070513 | death domain binding(GO:0070513) |
2.4 | 12.2 | GO:0034452 | dynactin binding(GO:0034452) |
2.4 | 7.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
2.4 | 7.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
2.4 | 14.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.4 | 9.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.4 | 7.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.4 | 7.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.4 | 14.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.4 | 7.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.3 | 7.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
2.3 | 25.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.3 | 9.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.3 | 18.4 | GO:0005522 | profilin binding(GO:0005522) |
2.3 | 9.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
2.3 | 9.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.3 | 20.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
2.3 | 6.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
2.2 | 13.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
2.2 | 6.7 | GO:0046980 | tapasin binding(GO:0046980) |
2.2 | 2.2 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
2.2 | 6.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
2.2 | 2.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
2.2 | 2.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.2 | 6.5 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
2.1 | 10.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.1 | 15.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
2.1 | 10.7 | GO:0009374 | biotin binding(GO:0009374) |
2.1 | 40.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.1 | 21.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.1 | 31.8 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
2.1 | 8.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.1 | 6.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
2.1 | 20.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
2.1 | 8.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
2.1 | 8.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.0 | 8.2 | GO:0043495 | protein anchor(GO:0043495) |
2.0 | 83.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
2.0 | 10.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
2.0 | 10.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 18.4 | GO:0005112 | Notch binding(GO:0005112) |
2.0 | 6.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.0 | 6.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.0 | 2.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
2.0 | 4.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.0 | 22.0 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
2.0 | 6.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.0 | 12.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
2.0 | 21.9 | GO:0030275 | LRR domain binding(GO:0030275) |
2.0 | 5.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.0 | 13.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.0 | 7.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
2.0 | 11.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.9 | 5.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.9 | 7.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.9 | 5.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.9 | 34.5 | GO:0050699 | WW domain binding(GO:0050699) |
1.9 | 19.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
1.9 | 5.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.9 | 9.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.9 | 5.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.9 | 11.4 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
1.9 | 3.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.9 | 5.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.9 | 9.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.9 | 9.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.8 | 3.7 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.8 | 5.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.8 | 3.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.8 | 5.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.8 | 7.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.8 | 16.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.8 | 5.4 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
1.8 | 18.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.8 | 69.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.8 | 17.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.8 | 3.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.8 | 14.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.8 | 5.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.8 | 10.6 | GO:0008143 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
1.7 | 7.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
1.7 | 10.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
1.7 | 8.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.7 | 1.7 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
1.7 | 5.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 1.7 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
1.7 | 6.9 | GO:0034618 | arginine binding(GO:0034618) |
1.7 | 27.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.7 | 20.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.7 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.7 | 11.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.7 | 3.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.7 | 3.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.7 | 18.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.7 | 6.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.7 | 6.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.7 | 11.6 | GO:0030507 | spectrin binding(GO:0030507) |
1.6 | 4.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.6 | 6.6 | GO:0035173 | histone kinase activity(GO:0035173) |
1.6 | 47.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.6 | 9.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.6 | 1.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.6 | 6.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.6 | 6.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.6 | 9.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.6 | 6.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.6 | 6.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.6 | 6.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
1.6 | 28.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.6 | 4.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.6 | 14.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.6 | 23.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.6 | 6.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.6 | 7.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.6 | 6.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.6 | 9.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.6 | 6.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.5 | 6.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.5 | 7.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.5 | 4.6 | GO:0030276 | clathrin binding(GO:0030276) |
1.5 | 6.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.5 | 4.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.5 | 1.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.5 | 4.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
1.5 | 12.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.5 | 10.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.5 | 4.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.5 | 9.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.5 | 9.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.5 | 10.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.5 | 12.0 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
1.5 | 1.5 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
1.5 | 6.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.5 | 4.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.5 | 6.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.5 | 24.0 | GO:0043621 | protein self-association(GO:0043621) |
1.5 | 7.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.5 | 11.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.5 | 8.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.5 | 14.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.5 | 11.7 | GO:0030371 | translation repressor activity(GO:0030371) |
1.5 | 8.7 | GO:0042805 | actinin binding(GO:0042805) |
1.5 | 1.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.5 | 17.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.5 | 8.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.5 | 4.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.5 | 5.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.4 | 10.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.4 | 7.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
1.4 | 8.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.4 | 123.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.4 | 5.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.4 | 5.7 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
1.4 | 7.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.4 | 5.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.4 | 2.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.4 | 2.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.4 | 4.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.4 | 2.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.4 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.4 | 1.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.4 | 18.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
1.4 | 36.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.4 | 4.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.4 | 15.3 | GO:0043531 | ADP binding(GO:0043531) |
1.4 | 6.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.4 | 18.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
1.4 | 9.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.4 | 15.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
1.4 | 9.6 | GO:0030332 | cyclin binding(GO:0030332) |
1.4 | 6.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.4 | 2.7 | GO:0031013 | troponin I binding(GO:0031013) |
1.4 | 13.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.4 | 4.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.4 | 4.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.4 | 8.1 | GO:0030274 | LIM domain binding(GO:0030274) |
1.4 | 5.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.3 | 16.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.3 | 18.8 | GO:0005035 | death receptor activity(GO:0005035) |
1.3 | 2.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.3 | 42.8 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
1.3 | 2.7 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
1.3 | 8.0 | GO:0070402 | NADPH binding(GO:0070402) |
1.3 | 13.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
1.3 | 5.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.3 | 2.7 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
1.3 | 22.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.3 | 6.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
1.3 | 4.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.3 | 6.6 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
1.3 | 3.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.3 | 6.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.3 | 3.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.3 | 5.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 1.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
1.3 | 36.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.3 | 19.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
1.3 | 7.8 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
1.3 | 62.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.3 | 30.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.3 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.3 | 2.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.3 | 3.8 | GO:0045545 | syndecan binding(GO:0045545) |
1.3 | 9.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.3 | 26.9 | GO:0030145 | manganese ion binding(GO:0030145) |
1.3 | 2.6 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
1.3 | 2.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.3 | 8.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.3 | 6.3 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
1.3 | 17.7 | GO:0070888 | E-box binding(GO:0070888) |
1.3 | 5.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.3 | 3.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.3 | 12.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.3 | 10.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.3 | 2.5 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.3 | 5.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.3 | 2.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.3 | 5.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.2 | 3.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.2 | 8.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.2 | 8.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.2 | 6.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
1.2 | 13.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.2 | 29.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.2 | 89.6 | GO:0008565 | protein transporter activity(GO:0008565) |
1.2 | 7.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.2 | 5.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.2 | 11.2 | GO:0005048 | signal sequence binding(GO:0005048) |
1.2 | 2.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 3.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.2 | 11.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.2 | 4.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.2 | 3.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.2 | 3.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.2 | 3.7 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
1.2 | 3.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.2 | 7.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
1.2 | 14.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.2 | 3.6 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.2 | 4.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.2 | 13.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.2 | 3.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.2 | 8.4 | GO:0003785 | actin monomer binding(GO:0003785) |
1.2 | 16.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.2 | 11.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.2 | 2.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.2 | 4.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.2 | 1.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.2 | 3.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
1.2 | 9.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.2 | 7.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
1.2 | 5.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.2 | 17.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.2 | 42.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
1.2 | 3.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.2 | 7.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.2 | 17.5 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
1.2 | 7.0 | GO:0000975 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) transcription regulatory region DNA binding(GO:0044212) |
1.2 | 2.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.2 | 7.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.2 | 8.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.2 | 8.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
1.2 | 34.8 | GO:0008134 | transcription factor binding(GO:0008134) |
1.2 | 4.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.2 | 2.3 | GO:0048185 | activin binding(GO:0048185) |
1.2 | 68.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
1.2 | 10.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 3.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.1 | 9.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.1 | 3.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.1 | 3.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 72.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.1 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.1 | 4.5 | GO:0016887 | ATPase activity(GO:0016887) |
1.1 | 6.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.1 | 7.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.1 | 12.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.1 | 6.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.1 | 3.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.1 | 9.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.1 | 10.1 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
1.1 | 1.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
1.1 | 6.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.1 | 3.4 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
1.1 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.1 | 13.4 | GO:0030552 | cAMP binding(GO:0030552) |
1.1 | 4.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.1 | 5.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 4.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.1 | 8.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.1 | 3.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.1 | 4.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.1 | 41.1 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
1.1 | 4.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.1 | 7.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.1 | 18.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.1 | 2.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
1.1 | 11.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.1 | 14.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.1 | 4.4 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.1 | 1.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.1 | 1.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
1.1 | 4.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
1.1 | 3.3 | GO:0030172 | troponin C binding(GO:0030172) |
1.1 | 3.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.1 | 6.5 | GO:0000339 | RNA cap binding(GO:0000339) |
1.1 | 9.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.1 | 5.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.1 | 1.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
1.1 | 2.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.1 | 1.1 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
1.1 | 38.3 | GO:0042393 | histone binding(GO:0042393) |
1.1 | 5.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.1 | 28.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.1 | 1.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.1 | 139.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
1.1 | 23.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
1.1 | 17.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.1 | 6.3 | GO:0043236 | laminin binding(GO:0043236) |
1.1 | 3.2 | GO:0031014 | troponin T binding(GO:0031014) |
1.0 | 1.0 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
1.0 | 2.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.0 | 111.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
1.0 | 97.8 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
1.0 | 2.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.0 | 3.1 | GO:0043515 | kinetochore binding(GO:0043515) |
1.0 | 2.1 | GO:0002039 | p53 binding(GO:0002039) |
1.0 | 4.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
1.0 | 4.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
1.0 | 5.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 2.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
1.0 | 9.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.0 | 1.0 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
1.0 | 19.5 | GO:0010843 | obsolete promoter binding(GO:0010843) |
1.0 | 2.0 | GO:0031404 | chloride ion binding(GO:0031404) |
1.0 | 3.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.0 | 7.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 20.4 | GO:0019003 | GDP binding(GO:0019003) |
1.0 | 3.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 25.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
1.0 | 16.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.0 | 4.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.0 | 3.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
1.0 | 8.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
1.0 | 2.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.0 | 19.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
1.0 | 4.0 | GO:0016208 | AMP binding(GO:0016208) |
1.0 | 2.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.0 | 3.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.0 | 19.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.0 | 1.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
1.0 | 3.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.0 | 4.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.0 | 2.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.0 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.0 | 3.0 | GO:0009055 | electron carrier activity(GO:0009055) |
1.0 | 170.5 | GO:0003924 | GTPase activity(GO:0003924) |
1.0 | 61.0 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
1.0 | 2.9 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.0 | 11.8 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
1.0 | 4.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.0 | 13.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.0 | 2.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.0 | 2.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 16.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.0 | 5.8 | GO:0030506 | ankyrin binding(GO:0030506) |
1.0 | 1.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
1.0 | 27.1 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
1.0 | 2.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.0 | 3.9 | GO:0017069 | snRNA binding(GO:0017069) |
1.0 | 7.7 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
1.0 | 7.7 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
1.0 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.0 | 11.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.0 | 7.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.0 | 2.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
1.0 | 18.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
1.0 | 6.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.0 | 10.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.9 | 3.8 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 1.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 4.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.9 | 1.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.9 | 6.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.9 | 3.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.9 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 5.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.9 | 2.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 0.9 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.9 | 7.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.9 | 72.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.9 | 24.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.9 | 2.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.9 | 3.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.9 | 2.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.9 | 2.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.9 | 11.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 2.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.9 | 11.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.9 | 73.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.9 | 3.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.9 | 28.7 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.9 | 7.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.9 | 23.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.9 | 15.1 | GO:0019955 | cytokine binding(GO:0019955) |
0.9 | 8.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.9 | 5.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.9 | 18.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.9 | 2.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.9 | 10.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.9 | 28.0 | GO:0051287 | NAD binding(GO:0051287) |
0.9 | 95.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.9 | 3.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 489.2 | GO:0003723 | RNA binding(GO:0003723) |
0.9 | 13.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 2.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.9 | 2.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.9 | 6.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 6.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.9 | 0.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.9 | 3.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.9 | 2.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.9 | 0.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.9 | 6.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.9 | 5.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.8 | 4.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.8 | 4.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.8 | 26.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.8 | 3.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.8 | 3.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.8 | 1.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.8 | 9.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.8 | 5.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.8 | 5.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.8 | 1.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.8 | 6.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.8 | 4.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.8 | 10.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.8 | 1.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.8 | 7.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 6.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.8 | 2.5 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 15.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.8 | 2.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.8 | 13.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.8 | 1037.8 | GO:0003677 | DNA binding(GO:0003677) |
0.8 | 14.7 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.8 | 3.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.8 | 0.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.8 | 9.7 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.8 | 28.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.8 | 4.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.8 | 7.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.8 | 4.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.8 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 4.0 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.8 | 1.6 | GO:0045502 | dynein binding(GO:0045502) |
0.8 | 62.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 23.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.8 | 4.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.8 | 7.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.8 | 15.0 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.8 | 186.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.8 | 11.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.8 | 1.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 10.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.8 | 9.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.8 | 12.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.8 | 6.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 4.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 5.4 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 3.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 0.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.8 | 9.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.8 | 2.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.8 | 3.8 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.8 | 2.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 3.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.8 | 2.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 5.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.8 | 15.1 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.8 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 3.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.8 | 3.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 143.8 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.7 | 5.2 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.7 | 17.9 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.7 | 13.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.7 | 5.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.7 | 1.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.7 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 7.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 3.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 7.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.7 | 4.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.7 | 85.1 | GO:0005525 | GTP binding(GO:0005525) |
0.7 | 10.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.7 | 2.9 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.7 | 1.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.7 | 73.5 | GO:0016874 | ligase activity(GO:0016874) |
0.7 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 6.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.7 | 23.6 | GO:0004518 | nuclease activity(GO:0004518) |
0.7 | 1.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.7 | 17.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.7 | 2.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.7 | 1.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 2.8 | GO:0016653 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.7 | 16.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.7 | 0.7 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.7 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.7 | 2.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 6.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.7 | 5.4 | GO:0005537 | mannose binding(GO:0005537) |
0.7 | 2.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.7 | 2.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 2.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.7 | 4.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 108.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.7 | 2.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.7 | 8.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.7 | 6.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.7 | 2.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.7 | 6.6 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.7 | 1.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.7 | 3.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.7 | 5.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 3.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 15.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.6 | 3.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.6 | 15.8 | GO:0005516 | calmodulin binding(GO:0005516) |
0.6 | 1.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.6 | 5.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 1.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 4.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.6 | 1.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 9.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.6 | 6.1 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.6 | 5.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 2.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.6 | 4.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 6.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 4.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.6 | 1.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 1.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 4.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.6 | 0.6 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.6 | 1.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.6 | 2.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.6 | 1.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.6 | 21.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.6 | 1.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 11.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 4.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 3.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.6 | 13.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.6 | 5.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.6 | 6.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.6 | 33.6 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.6 | 1.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 13.1 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.6 | 27.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.6 | 23.7 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.6 | 1.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 256.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.6 | 106.8 | GO:0003779 | actin binding(GO:0003779) |
0.6 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 9.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.6 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 1.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.5 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 1.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.5 | 1.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.5 | 5.1 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.5 | 2.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 4.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.5 | 2.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.5 | 5.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.5 | 37.6 | GO:0003774 | motor activity(GO:0003774) |
0.5 | 33.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.5 | 3.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 19.8 | GO:0019900 | kinase binding(GO:0019900) |
0.5 | 2.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 0.5 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.5 | 5.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.5 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 5.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.5 | 1.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 2.7 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 1.8 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.4 | 2.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 1.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 3.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 2.2 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.4 | 5.7 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.4 | 3.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.4 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 0.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 5.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 6.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.4 | 13.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 10.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.4 | 0.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.4 | 1.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.4 | 2.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 10.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.4 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.4 | 1.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 851.2 | GO:0005515 | protein binding(GO:0005515) |
0.4 | 56.7 | GO:0035639 | purine ribonucleoside triphosphate binding(GO:0035639) |
0.4 | 6.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.4 | 5.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 5.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 0.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 0.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 4.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.3 | 0.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 0.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.3 | 0.7 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.3 | 1.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.3 | 0.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.3 | 3.9 | GO:0016772 | transferase activity, transferring phosphorus-containing groups(GO:0016772) |
0.3 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 5.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 3.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 1.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 1.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 2.4 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.3 | 85.6 | GO:0016787 | hydrolase activity(GO:0016787) |
0.3 | 10.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 3.5 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.2 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 168.1 | GO:0005488 | binding(GO:0005488) |
0.2 | 4.2 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
0.2 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.2 | GO:0016491 | oxidoreductase activity(GO:0016491) |
0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.8 | GO:0004871 | signal transducer activity(GO:0004871) |
0.1 | 0.1 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.0 | 0.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.8 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 4.5 | GO:0005215 | transporter activity(GO:0005215) |
0.0 | 0.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 8.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 3.8 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 4.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.9 | 31.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.6 | 28.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.5 | 42.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.5 | 41.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
2.4 | 102.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
2.4 | 111.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
2.3 | 23.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.3 | 4.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.2 | 20.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.2 | 51.3 | PID IFNG PATHWAY | IFN-gamma pathway |
2.2 | 8.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.1 | 38.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.1 | 10.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.1 | 4.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
2.1 | 56.6 | PID FOXO PATHWAY | FoxO family signaling |
2.1 | 12.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.1 | 2.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
2.0 | 72.5 | PID BCR 5PATHWAY | BCR signaling pathway |
2.0 | 27.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.9 | 11.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.9 | 33.8 | PID REELIN PATHWAY | Reelin signaling pathway |
1.9 | 33.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.8 | 12.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.8 | 32.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
1.8 | 3.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.7 | 22.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.7 | 20.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.6 | 68.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.6 | 8.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.6 | 47.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.6 | 9.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.6 | 4.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.6 | 15.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.6 | 3.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.6 | 92.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.6 | 17.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.6 | 10.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.5 | 12.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.5 | 57.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.5 | 21.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.5 | 11.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.5 | 1.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.4 | 26.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.4 | 54.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.4 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.4 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.4 | 15.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.4 | 34.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.3 | 9.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.3 | 14.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.3 | 26.6 | PID BARD1 PATHWAY | BARD1 signaling events |
1.3 | 9.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.3 | 6.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.3 | 30.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.3 | 40.6 | PID ATR PATHWAY | ATR signaling pathway |
1.3 | 10.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.3 | 11.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.3 | 16.6 | PID AURORA A PATHWAY | Aurora A signaling |
1.3 | 5.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.3 | 28.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.2 | 56.0 | PID P73PATHWAY | p73 transcription factor network |
1.2 | 40.9 | PID CDC42 PATHWAY | CDC42 signaling events |
1.2 | 21.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.2 | 12.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.2 | 12.3 | PID MYC PATHWAY | C-MYC pathway |
1.2 | 27.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.2 | 34.1 | PID PLK1 PATHWAY | PLK1 signaling events |
1.2 | 44.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.2 | 26.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.2 | 14.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 7.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.2 | 2.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.2 | 2.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.2 | 29.1 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 1.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.1 | 3.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.1 | 40.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.1 | 4.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.1 | 5.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.0 | 17.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.0 | 2.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.0 | 14.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.0 | 11.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.0 | 11.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 12.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.0 | 9.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.0 | 15.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.0 | 17.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.0 | 2.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.0 | 13.7 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 6.8 | PID ATM PATHWAY | ATM pathway |
1.0 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 27.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.0 | 4.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.0 | 46.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
1.0 | 33.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.0 | 3.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.0 | 14.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.9 | 4.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.9 | 18.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.9 | 33.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.9 | 12.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.9 | 12.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.9 | 7.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.9 | 13.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 45.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.8 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 11.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 4.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 9.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 11.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.8 | 20.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 16.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 5.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 3.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.7 | 5.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 3.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 8.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 11.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 18.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 5.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.7 | 13.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 12.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.7 | 7.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 14.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.6 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 5.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.6 | 1.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.6 | 6.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 4.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 6.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 3.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 13.1 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 10.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 2.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 6.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 9.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.5 | 4.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 10.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 7.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 5.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 8.9 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 2.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 3.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 7.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 5.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 0.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 7.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 4.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 5.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 3.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 2.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 2.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 2.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 4.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 5.8 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 2.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 6.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 10.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 5.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 4.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
3.1 | 3.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
3.0 | 3.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.7 | 5.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.6 | 38.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.5 | 5.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
2.4 | 4.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
2.3 | 52.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
2.3 | 27.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.2 | 17.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.2 | 2.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
2.2 | 64.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.2 | 46.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
2.2 | 15.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.1 | 2.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
2.1 | 28.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.0 | 14.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
2.0 | 73.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
2.0 | 91.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
2.0 | 6.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.0 | 54.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
2.0 | 4.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.0 | 9.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
2.0 | 2.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.9 | 29.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.9 | 25.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.9 | 5.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.9 | 42.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.9 | 20.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.9 | 5.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.9 | 13.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.9 | 16.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.8 | 5.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.8 | 10.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.8 | 21.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.8 | 17.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.8 | 14.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.8 | 29.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.8 | 7.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.7 | 24.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.7 | 1.7 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
1.7 | 30.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.7 | 17.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.7 | 18.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.7 | 31.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.7 | 5.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.7 | 38.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.6 | 4.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.6 | 27.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.6 | 22.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.6 | 23.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.6 | 26.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.5 | 41.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.5 | 9.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.5 | 6.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.5 | 19.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.5 | 24.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.5 | 10.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.5 | 7.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.5 | 4.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.5 | 33.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.5 | 28.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.5 | 58.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
1.5 | 26.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.5 | 28.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
1.5 | 11.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.5 | 32.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
1.5 | 5.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.5 | 14.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.5 | 14.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.5 | 11.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.5 | 4.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
1.4 | 26.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.4 | 18.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.4 | 25.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.4 | 42.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.4 | 8.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.4 | 36.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.4 | 30.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.4 | 19.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.4 | 6.8 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.4 | 10.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.4 | 9.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.3 | 9.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.3 | 18.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.3 | 12.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.3 | 27.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.3 | 6.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.3 | 13.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.3 | 118.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
1.3 | 23.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.3 | 21.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.3 | 11.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.3 | 9.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.3 | 26.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.3 | 22.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.3 | 30.4 | REACTOME KINESINS | Genes involved in Kinesins |
1.3 | 7.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.3 | 20.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.3 | 2.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.3 | 16.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.2 | 5.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.2 | 13.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.2 | 22.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.2 | 4.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.2 | 7.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.2 | 46.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.2 | 8.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.2 | 9.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 8.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.2 | 14.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.2 | 187.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.2 | 45.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.2 | 2.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.2 | 7.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.1 | 41.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
1.1 | 9.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.1 | 18.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
1.1 | 19.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.1 | 18.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 55.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.1 | 6.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.1 | 8.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.1 | 2.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.1 | 7.6 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
1.1 | 19.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.1 | 20.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.1 | 6.5 | REACTOME S PHASE | Genes involved in S Phase |
1.1 | 9.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.1 | 3.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.1 | 1.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
1.1 | 14.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.1 | 25.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.0 | 5.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 4.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.0 | 16.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.0 | 9.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.0 | 13.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.0 | 8.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
1.0 | 5.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.0 | 4.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 11.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
1.0 | 3.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.0 | 4.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.0 | 4.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 21.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.0 | 6.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.0 | 10.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.0 | 12.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.0 | 10.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.0 | 47.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 12.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 10.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 54.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.9 | 1.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.9 | 117.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.9 | 1.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 8.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 1.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.9 | 35.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.9 | 11.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.9 | 16.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.9 | 9.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.9 | 35.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.9 | 2.6 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.9 | 11.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 14.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 15.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.9 | 11.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 26.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 3.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.9 | 40.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 13.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.9 | 41.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.9 | 6.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.8 | 9.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 9.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 18.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.8 | 17.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.8 | 15.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 5.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.8 | 2.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.8 | 14.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 46.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.8 | 195.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.8 | 16.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.8 | 3.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.8 | 17.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 6.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 6.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.8 | 25.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.7 | 4.4 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.7 | 0.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.7 | 15.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.7 | 1.4 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.7 | 15.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.7 | 3.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 3.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.7 | 3.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 27.6 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.7 | 0.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 6.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 7.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 8.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.7 | 5.9 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.6 | 14.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 8.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 8.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.6 | 14.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 1.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.6 | 36.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 1.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.6 | 19.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 2.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 2.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 17.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.6 | 3.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.6 | 13.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 4.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 3.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 8.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 3.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 6.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.5 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 2.0 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.5 | 5.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.5 | 4.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 21.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 2.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.5 | 6.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 4.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 4.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 16.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 43.2 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.4 | 16.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.4 | 5.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 0.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 6.0 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.4 | 7.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.4 | 11.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 2.8 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.4 | 9.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.4 | 5.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.4 | 1.1 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.4 | 4.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 13.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 1.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.3 | 3.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 7.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 0.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 12.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 6.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 4.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 15.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.3 | 3.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 7.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 3.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 1.6 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.2 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 12.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.3 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.2 | 2.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 5.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.2 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.8 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 2.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 7.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |